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ABSTRACT
In rabbits, the majority of the antibody diversity is generated in gut-associated
lymphoid tissues (GALT) where B cells migrate after leaving the bone marrow (BM). B
cells that seed GALT expand polyclonally, and the immunoglobulin (Ig) genes of
essentially all B cells undergo somatic diversification leading to an expanded primary
antibody repertoire. Somatic diversification of the Ig genes occurs by somatic
hypermutation and also by somatic gene conversion. These processes occur in an
antigen- and T cell-independent mechanism. The development and expansion of the
antibody repertoire requires interaction of GALT with intestinal microbiota.
Serum Ig secreted from the B cells of normal rabbits shows a predominant VHa
allotype over the VHn allotype. In contrast to this, ali/ali mutant rabbits (Alicia), which
contain two mutant VHa2 alleles, show at birth a prevalence of the VHn allotype. Upon
contact with the gut microbiota, the ali/ali rabbit VHn B cell population stops
proliferating and in turn, cells with VHa allotype start expanding. These events do not
occur by gene replacement or by secondary Ig gene rearrangement on the unexpressed Ig
allele. It is possible however, that the expansion of VHa cell takes place by selective
expansion induced by the intestinal microbiota.
Bacteria promote B cell proliferation and the formation of B cell follicles. In
addition, rabbits raised under germ-free conditions have under-developed GALT and

xii

poor antibody responses to antigenic challenges. The molecular mechanism by which
bacteria promote GALT development and function remains unclear.
For my thesis I investigated the mechanism by which commensals drive GALT
reactions, particularly the processes that lead to the activation and migration of B cells in
GALT. The Knight Lab model suggests that B cells that enter GALT follow a
chemokine gradient to the follicular associated epithelium (FAE), where they may
encounter bacteria. These events presumably provide the B cells with signals that may
lead to their activation and relocation to other regions of the follicle. B cells can be
activated in a T cell independent stimulation by B cell receptor (BCR) engagement, or
through Toll-like receptor (TLR) signaling. I hypothesized that surface molecules of
selected bacterial species in the gut of rabbits cause the activation and expansion of B
cells.
To determine if commensals bind surface Ig I isolated bacteria from the intestines
of rabbits, and found that commensal can bind to Ig, independently of their specificity.
Particularly, I detected a ~20kDa bacterial molecule from at least three species that
immunoprecipitated with FvIg. To determine whether bacteria provide signals for
activation and migration, I stimulated B cells with bacterial molecules and detected the
expression of B7, which is expressed on activated B cells but not on resting B cells. I
found that bacterial molecules from commensals provide signals that induce the
activation of B cells. In addition, I stimulated cells through BCR or through TLR2, and

xiii

found an increase in the expression of chemokine receptors (CCR6, CXCR5, CCR7 and
CXCR4), known to be expressed on B cells as they move throughout the follicle.
The evidence collected in these studies suggests that bacterial molecules can bind
to B cells via surface Ig. This supports the idea that in the FAE bacteria provide B cells
with signals that may lead to their activation.
These studies provide insights into the mechanism by which interactions between
the host and intestinal microbiota alter the B cell repertoire in an antigen independent
manner. My findings contribute to our current model of B cell activation and migration
in GALT.
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CHAPTER ONE
LITERATURE REVIEW

ANTIBODY DIVERSITY
Theories of Antibody Diversity
With the discovery of antibodies (Ab) in the last decade of the 1800s, the
scientific community became interested in the mechanism that leads to antibody
diversity. In 1897 P. Ehrlich published his “Selectionistic Theory”, which stated that Ab
producing cells expressed a large variety of receptors on the cell surface, each able to
interact with a different antigen (Ag). Ehrlich proposed that these preformed Abs can
associate with a particular toxin or Ag "like a key in a lock“, causing stimulation for the
production of more Ab to released to into the blood (Brand and Roth, 2008). However,
this theory could not explain how Abs are developed against practically any molecule in
nature, and was later dismissed.
A few decades later the “Instructionistic Theory” was explained by L. Pauling and
F. Haurowitz. This theory stated that the Ab protein was a template molecule that could
be folded into specific shapes by the interaction/instruction with Ag. Once folded into a
specific shape, the Ab would subsequently interact only with that particular Ag. This
hypothesis could not explain affinity maturation, self/nonself discrimination, how Ab
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continues to be produced in the absence of Ag, or why secondary responses are much
more rapid and robust than the initial immune response (Brand and Roth, 2008).
The “Clonal Selection Theory” was proposed a few years later by F. M. Burnet,
D. W. Talmage and J. Lederberg. This theory stated that each Ab-producing cell bears,
through a random process, Abs of a single molecular species unique for a specific Ag.
According to this postulate, when an Ag binds its specific Ab, it induces both the clonal
expansion of Ab-producing cells, and the creation of a population of memory cells
(Llewelyn, 1992; Hood, 2008). This theory could not explain how a limited number of
genes could provide an infinite number of Ag specificities (Brand and Roth, 2008).
Around the same time, W. J. Dreyer and J. C. Bennett revolutionized the
Immunology field with their “Germline Theory” for Ab diversity, which stated that many
genes existed to encode each Ab (Gearhart, 2006). By then, it was known that Abs are
composed of a variable region (V) and a constant region (C), but it was not known
whether one gene or more was involved in the expression of the whole protein. The
finding that each antibody had its own amino acid sequence in the variable region
suggested a separate gene for each antibody chain produced. They proposed that each
class of C region is encoded by one gene, but that large numbers of genes exist for the V
domains (VH and VL). In addition, they correctly suggested that antibody genes would be
formed by recombination between these genes during B cell development (Llewelyn,
1992).
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Five years later, in 1970, T. T. Wu and E. A. Kabat successfully mapped and
aligned all of the amino acid sequences of the Abs, determining their variability. Using
these sequences, they created a metric of variability at each amino acid residue position,
and plotted this variability across the 107 residues of the light chain V region. This
diversity figure led them to identify extreme hypervariable regions: the Ag-binding or
complementarity-determining region (CDR) of the Ab light (L) chain. This led them to
the proposal of the “Somatic Theory” for antibody diversity. They suggested that the
CDRs were encoded by episomes that were able to recombine with a few germline genes,
consequently creating a somatic mechanism for generating Ab diversity (Hood, 2008).
The controversy over how Ab diversity occurs was put to an end with the
publication by S. Tonegawa and N. Hozumi, in 1976. They showed indisputable data
that provided evidence for the rearrangement of Ig genes. Their approach was to
compare DNA from Balb/c mouse early embryos with that from plasmacytoma cells
(differentiated cells). By nucleic acid hybridization experiments they found that the
pattern of embryo DNA showed two components, one of which hybridized with C-gene
sequences and the other with V-gene sequences. The pattern of the tumor DNA showed a
single component that hybridized with both V-gene and C-gene sequences, and that it was
smaller than either of the components in embryo DNA (Hozumi and Tonegawa, 1976).
Their results was the first direct evidence that showed that separate genes encode the V
and C regions of Abs, and that genes are somatically rearranged during B-cell
differentiation (Brand and Roth, 2008).
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In the years that followed, the J (joining) segment of both L and heavy (H) chains
was identified. In 1980 P. Early and L. Hood identified the D (diversity) segment of
VH(D)JH by isolating myeloma clones and sequencing the V and J regions
(independently), and comparing them with the sequence of a rearranged VH gene
encoding the complete heavy chain. They found that there were non-coding sequences
that include conserved nucleotides in both the V and the J regions. Moreover, they
observed in the rearranged VH gene solely, the presence of nucleotides encoding a few
extra amino acids. They proposed that these nucleotides originated from a third germline
gene segment, which they named “D” for diversity (Early, 1980).
Several other mechanisms that are involved in the antibody diversity were
identified over the past three decades. These include the activation-induced deaminase
(AID), which initiates hypermutation by modifying Ig genes (Gearhart, 2006); and the
recombination activating gene 1/2 (RAG-1/2), actively involved in gene recombination
(Brand and Roth, 2008).
Every theory formulated over the years to explain the mechanism of Ab diversity
was partially correct. Each of them contributed to the modern understanding of how
huge numbers of Ags are recognized by Abs. We now know that the recombination of
hundreds of gene segments, somatic hypermutation and affinity maturation are combined
to generate Ab diversity. This remarkable process is completed by the natural
mechanism of selection.

5
Site of antibody diversification in rabbits
In humans and mice, combinatorial joining of multiple V, D, and J gene segments
results in a vast array of V(D)J genes that form the primary Ab repertoire (Vajdy, 1998).
However, other species like chicken, sheep and rabbit, which utilize a very limited
number of VH and VL genes in the V(D)J gene rearrangements, use a different strategy to
increase their poor combinatorial mechanism. Their primary antibody repertoire is
diversified post-rearrangement by either somatic gene conversion or somatic
hypermutation, or both (Pinheriro, 2011). In the case of rabbits, the immunoglobulin
heavy chain (IgH) locus contains approximately 100 VH gene segments; however, VH1
(3’-most VH gene) is preferentially used in the V(D)J gene rearrangements in most B cells
(Knight and Becker, 1990).
The diversification of the Ab repertoire in chickens occurs in the bursa of
Fabricius shortly after hatching, and for sheep it occurs in the ileal Peyer’s patches after
birth; in rabbits this process occurs in the appendix. This was first suggested by Cooper
(1968) after performing neonatal appendectomies and finding that these rabbits had
reduced numbers of circulating lymphocytes and immunoglobulins. This was later
confirmed when rearranged VH region genes of B cells isolated from the appendix of 6
weeks old rabbits were sequenced. The results demonstrated that the primary antibody
repertoire occurs early in rabbit B cell development within the appendix germinal centers,
and that it may occur by gene conversion and somatic hypermutation (Knight and Crane,
1994; Weinstein, 1994).
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THE RABBIT AS A MODEL ORGANISM
Historical perspective of the rabbit as a model organism
As an animal model, the rabbit has historically been used in a variety of
biomedical research areas, toxicology studies, and for research involving the immune
system (Püschel, 2010). To this day, the rabbit is still widely used in research, primarily
because of the high quality and quantity of its antibodies. Studies of the rabbit immune
system have greatly contributed to our knowledge of the structure, function and
regulation of antibodies (Pinheiro, et al., 2011). This organism has also been used in all
types of basic science studies, including nutrition, reproduction, and embryology (Craig,
2012).
Rabbits originated in the Iberian Peninsula around 2000 B.C. Some attempts at
domestication were made during the Greek and Roman periods however, true
domestication was not initiated until about the l6th century. The first scattered reports of
the use of rabbits as laboratory animals began to appear by the middle of the 19th century
(Püschel, 2010; Pinheiro, et al., 2011).
The rabbit family includes 10 genera and 25 species. The European rabbit
(Oryctolagus cuniculus) diverged into two subspecies, O. cuniculus algirus and O.
cuniculus cuniculus, approximately 1.8 million years ago. The worldwide migration of
humans over the centuries has mediated the dispersal of this species. We can now find
the European rabbit in Continental Europe, England, Australia, New Zealand, North and
South America, and North Africa (Pinheiro, et al., 2011).
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Allotypic divergence of rabbit antibodies
In rabbits, B cell development occurs in bone marrow (BM), and nearly all VDJ
gene rearrangements utilize the same VH gene, VH1. This factor limits the extent to
which combinatorial joining of multiple V genes contributes to antibody diversity (Knight
and Becker, 1990).
The unique feature of Rabbit Ig allotypes set them apart from mice, humans and
other mammals. In rabbit, the gene locus controlling the V region of the IgH chain shows
extensive allelic diversity. The VH regions of rabbit antibodies can display different
allotypic motifs: a, x, y or z. Serological surveys of domestic rabbits defined three “apositive” allotypic lineages: a1, a2, and a3 (Pinheiro, et al. 2011). The divergence
between these allotypes is of approximately 20% amino acid sequence differences. The
allelic specificities of a1 and a2 are correlated with several amino acid differences in
framework regions (FR) 1 (Tonnelle, et al., 1983).
These allotypes are mostly encoded by the predominantly rearranged gene, VH1.
Serum Ig of rabbits typically reacts with anti-VHa1, anti-VHa2, or anti-VHa3 allotypic
antibodies. However, 10 to 20% of serum Ig does not react with these antibodies. This is
referred to as VHn (VHa-negative) Ig, which lacks VHa allotype-specific determinants
(Horng, 1976; Zhu, 1999; Esteves, 2004). VHnIg is encoded predominantly by VHx, VHy,
and VHz genes, which reside over 50 kb upstream of the VH1 gene (Zhu, 1999).
About 80 to 90% of circulating Ig molecules are derived from the VH1 gene and
express the VHa allotypic markers (Margolies, 1977). The VH regions of the remaining
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10 to 20% of Ig molecules are encoded by the VHn genes (Roux, 1981). The molecular
basis for preferential usage of the VH1 gene in VDJ rearrangements remains unanswered.

Alicia rabbit (ali/ali)
In 1986 Kelus and Weiss established a variant strain that originated from a
heterozygous a1/a2 male. These rabbits have a variant VHa2 allotype-encoding allele, ali,
which has a 10-kb deletion of genomic DNA encompassing VH1 (Becker and Knight,
1990; Allegrucci, et al., 1990). In contrast with wildtype rabbits, nearly all Ig in young
ali/ali rabbits (designated Alicia) are VHn.
Newborn Alicia rabbits possess a predominant VHn B cell population, but as these
rabbits age, the number of VHa B cells increases, becoming the predominant allotype
(Pospisil and Mage, 1998; Zhu, 1999). Mutant ali/ali rabbits lack the IgH VH gene
segment, VH1. Analysis of nucleotide sequences of the promoter region showed that
more than 80% of the VDJ rearrangements in older Alicia rabbits utilize either the
functional VH4 or VH7 genes localized upstream of VH1. The VH4 and the VH7 genes have
7 (out of 11) specific nucleotides associated with the allotype a2 (Zhu, 1999; Sehgal, et
al., 1998).
The VH4 gene encodes molecules known as VHa. However, the VHa-µ heavy
chains encoded by VH4 do not pair with surrogate light chain in the BM to form a
functional preBCR. Consequently, most VHa B-lineage cells do not pass the preB cell
checkpoint during B cell development and are deleted in the BM (Zhu, 1999). As a
result, cells utilizing VHn genes become the dominant B cell type that successfully
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develops in BM and exits to the periphery. These VHn B cells comprise the vast majority
of B cells in gut-associated lymphoid tissues (GALT) and in the periphery for the first 6
weeks of life (Pospisil, 1995). This dominance of VHn B cells changes dramatically
between 6 and 11 weeks of age, when the few VHa (VH4-utilizing) B cells that complete
development in the BM exit to the periphery, expand rapidly and become the dominant B
cell type.
Rhee, et al. (2004) demonstrated that this phenomenon does not arise from VH
gene replacement or from secondary Ig gene rearrangements on the unexpressed Ig allele,
as initially suggested. They also demonstrated that this shift occurs in GALT and
requires intestinal microbiota. Their results suggest that a B cell superantigen may
promote the positive selection of VHa B cells in GALT, by stimulating B cells in an
antigen-nonspecific, polyclonal manner (Rhee, et al., 2004).

B-CELL SUPERANTIGENS
Superantigens (SAgs) are bacterial molecules capable of triggering innate and
adaptive immune responses. SAgs were initially thought to interact exclusively with T
cells, and accordingly, their association to T lymphocytes has been extensively described.
In contrast to conventional antigens, SAgs do not require to be processed into peptides, or
even presented by major histocompatibility complex (MHC) molecules. Instead, the
intact SAg molecule binds outside the MHC groove and interacts directly with the T-cell
receptor (TCR) (Zouali, 1995).
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Extensive studies conducted in recent decades have concluded that SAgs are not
exclusive to T cells but have specificity for B cells as well. B cell superantigens are
molecules that bind to surface Ig outside of the conventional Ag binding site. These
bacterial molecules can stimulate B cell differentiation and Ig secretion. It has been
found that these molecules bind to conserved FR amino acid residues in the V region of
the heavy or light chains (VH or VL, respectively) (Severson, 2010).
Staphylococcus aureus protein A (SpA) is one such B cell superantigen. The
interactions of SpA with the fragment antigen-binding (Fab) region of membrane Igs can
stimulate a large fraction of B cells, contributing to lymphocyte polyclonal expansion.
The binding specificity is restricted to the Fab heavy chain VH3 family in humans and
other mammalian species. In the Fab, the residues in contact with SpA are located in the
VH region framework β-strands and the inter-strand loops most remote from the antigen
combining site (Graille, et al., 2000).
Rhee, et al. (2004) compared amino acid sequences of rabbit VHn and VHa Ig, and
identified a putative VH ligand binding site in the FR1 and FR3 regions for a bacterial B
cell superantigen. This study demonstrated that these binding sites are clustered on the
external face of the VH domain with their side chains exposed for potential interaction
with SAgs.
Superantigens are molecules that bind outside the conventional antigen binding
site. Since almost all B cells in rabbit utilize the same VH gene (VH1) during VDJ gene
rearrangements, it is possible that a bacterial superantigen interact with all B cells,
independent of their BCR specificity (Knight and Winstead, 1997).
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B CELL DEVELOPMENT
In mammals, B cells are generated from haematopoietic stem cells (HSCs). They
develop in the BM before they migrate into the blood to reach peripheral lymphoid
organs. Reticular cells, which surround BM sinuses, have been shown to be associated
with B cells, making them likely candidates for providing the factors required for B-cell
development. Both in vitro and in vivo studies indicate that osteoblasts are also essential
regulators of the development of B cells in the bone marrow. The mechanisms that
regulate the association between developing B cells and their cellular niches, including
microenvironmental factors, remain unclear (Nagasawa, 2006).
B cell precursors are divided in fractions A (pre-pro B cells), B (pro-B cells), C
(pro-B cells) and D (pre-B cells). This classification was arranged according to their
differential expression of a range of cell-surface markers during development in the bone
marrow. Immature B cells, which are generated from fraction D cells, exit the bone
marrow and reach the spleen, where they mature into peripheral mature B cells and
subsequently into plasma cells (Nagasawa, 2006). Plasma cells, which develop following
the activation of mature B cells by Ag in peripheral lymphoid organs, return and colonize
the BM. Most plasma cells, present in constant numbers in the BM, are long-lived and
not derived from the differentiation of proliferating, activated B cells (Manz, 1997).
During their development and differentiation, B cells undergo immunoglobulingene rearrangement. B cell precursors first assemble a heavy-chain DJ rearrangement,
which is then followed by heavy-chain variable (V)DJ gene rearrangements (Nagasawa,
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2006). In humans and mice, combinatorial joining of multiple V, D, and J gene segments
results in a vast array of V(D)J genes that form the primary Ab repertoire.
B cells that undergo combinatorial joining leave the bone marrow to seed the
periphery. This Ab repertoire is expanded further by somatic mutation after Ag
stimulation (Griffiths, 1984). The combinatorial joining of species like chicken (IgH and
IgL) and sheep (IgL) occurs by a limited number of V, D,and J gene segments followed
by somatic diversification of the V(D)J genes in an exogenous Ag-independent manner
(Reynaud, 1987; Reynaud, 1991). These immature B cells are now expressing a
functional BCR, which provides them with antigen specificity. Cells that successfully
cross this phase enter the periphery as transitional B cells.
The ability of the adaptive immune system to provide protection against
pathogens requires a diverse BCR repertoire that can recognize a broad range of foreign
molecules. Diversity is generated early in development by random rearrangement of
immunoglobulin genes, and by somatic hypermutation (Cambier, 2007).
In rabbits, most B cell development occurs in the BM early in ontogeny,
decreasing dramatically within a few months after birth. During their development in the
BM, the diversification of the B cell antibody specificities is limited. Knight and Becker
(1990) demonstrated that nearly all VDJ gene rearrangements utilize the same VH gene,
VH1, significantly limiting their antibody diversity. Instead, the majority of the antibody
diversity is generated in GALT between 3 and 8 weeks of age, where B cells migrate
after leaving the BM (Vajdy, 1998). The B cell expansion and the somatic diversification
of Ig genes occur by a gene conversion-like mechanism and by somatic hypermutation
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(Becker and Knight, 1990; Lanning and Knight, 1997). This process occurs in germinal
center-like structures in an antigen- and T cell-independent mechanism, as demonstrated
by Pospisil and Mage (1998). This differs from germinal center reactions in mice which
are dependent on antigenic stimulation. Other studies have shown that this process of
somatic diversification requires interaction of GALT with intestinal microbiota (Rhee, et
al., 2004).

GUT-ASSOCIATED LYMPHOID TISSUE (GALT)
The gut associated lymphoid tissue, is the largest collection of lymphoid tissues
located in the intestines of some mammals. GALT is composed of mesenteric lymph
nodes (mLNs) and Peyer’s patches (PP), and B and T lymphocytes in the intestinal
lamina propria (LP) and epithelium (Forchielli, 2005).
A Roman physician, Rufus of Ephesus, identified mLNs for the first time during
the second and first centuries BC. The PPs of the small intestine were discovered
centuries later by the Swiss anatomist Johann Conrad Peyer. The existence of PPs in the
cecum and colon of a number of small mammals was not reported until 1884, by the Irish
zoologist George Edward Dobson (Eberl and Lochner, 2009).
GALT is overlaid with specialized areas named follicle-associated epithelium
(FAE), which are involved in sampling and transporting antigens from the lumen of the
intestines to the mucosa. The FAE contains a varying number of thin membrane (M)
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cells with a unique ability to translocate antigens and a variety of bacteria into the
mucosa of the intestines (Yamanaka, 2003).

B cell expansion in GALT
It is well established that intestinal bacteria are essential for the normal structural
and functional development of the mucosal immune system. Studies on germfree mice
demonstrated that these exhibit smaller PPs and fewer intraepithelial lymphocytes,
compared to germfree mice colonized with single or multiple species of bacteria
(Forchielli, 2005). A recent study using germfree rats demonstrated in
immunohistochemistry experiments, that the FAE contains only a few T and B cells. It
was also observed that the B cells of these germfree rats were negative for B7, a costimulatory molecule necessary for T cell activation. After bacterial colonization,
activated B cells achieved a spatial position in the FAE facilitating their encounter with
luminal Ags (Yamanaka, et al. 2003).
In rabbits, the appendix, sacculus rotundus (SR), and PP comprise the GALT,
where B cells migrate after leaving the BM (Crane, 1996). To determine whether GALT
is necessary for generating the primary Ab repertoire in rabbits, Vajdy (1998) surgically
removed the organized GALT shortly after birth, and compared the antibody repertoire to
that of normal rabbits. This study showed by nucleotide sequence analysis that GALT, in
particular the appendix, is essential for the somatic diversification of IgM VDJ genes of
peripheral B cells. Additionally, the authors found diminishing numbers of peripheral B
cells after removal of the GALT. These findings also indicate that GALT functions as a
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primary lymphoid organ for the post-natal expansion of B cells. The rabbit appendix is
thought to function as a secondary lymphoid organ in adult rabbits (Weinstein, et al.,
1994b).
Later studies demonstrated that the intestinal microbiota, are necessary and
required for the diversification of the Ab repertoire, and B cell expansion in the rabbit.
This was first demonstrated by Lanning (2000) while examining VDJ gene diversification
of rabbits in which the appendix was ligated at birth to prevent microbial colonization.
By 12 weeks of age nearly 90% of the Ig VDJ genes were undiversified, indicating that
the intestinal microflora is required for somatically diversifying the Ab repertoire. A
similar arrest in B cell expansion and appendix follicle development is also observed in
new born rabbits with a ligated cecum (Hanson and Lanning, 2008). Colonization of
intestinal microbiota begins at birth. The maternal microbiota can be a source of bacteria
colonizing the newborn’s intestine. Colonization can also be affected by environmental
factors and by infant feeding patterns (Forchielli, 2005).
Hanson and Lanning (2008) demonstrated by in situ hybridization that B cells
enter GALT 2 days after birth and migrate to the FAE. Here, the cells presumably
receive signals from bacteria located in pockets of M cells located along the epithelium.
In addition to this, B cells may be stimulated by one or more of several mechanisms,
including CD40L and Toll-like receptors (TLRs) (Yeramilli, et al., 2011). The
stimulated B cells proliferate and upregulate activation-induced cytosine deaminase
(AID); and in the basolateral region of the follicle, the Ig genes undergo somatic
diversification.
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In rabbits, the development and expansion of the antibody repertoire are
dependent on interactions between GALT and the intestinal microbiota. Additionally, in
the appendix, SR and PP, bacteria promote B cell proliferation and the formation of B
cell follicles. However, not all bacterial species equally induce GALT development, as
demonstrated by Rhee, et al. (2004) when using different combinations of bacteria into
germfree appendices. In this study the combination of two bacterial species, Bacillus
subtilis and Bacillus fragilis, was sufficient to stimulate B cell development in rabbit
GALT. Finally, rabbits raised under germ-free conditions have under-developed GALT
and poor antibody responses to antigenic challenges (Rhee, et al., 2004). To this date the
molecular mechanism by which bacteria promote GALT development and function
remains unclear.
To investigate the mechanism by which bacteria promote B cell development in
GALT, K. Severson (2010) tested whether bacterial derived superantigen-like molecules
could mediate B cell proliferation in GALT. The authors of this study identified and
described a superantigen-like protein, ExsK, found on the surface of bacterial spores.
Their results suggested that surface proteins on bacterial spores may polyclonally
stimulate B cells and promote their development in GALT.

B CELL ACTIVATION
Resting and activated B cells display distinct phenotypes and functional
properties. Resting B cells are ineffectual whereas activated B cells are capable of
triggering T cell activation (Ding and Shevach, 1996). In addition, activated B cells can
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differentiate to form either plasma cells capable of antibody secretion, or memory cells
that provide long-lived protection against secondary infection (Harwood and Batista,
2010).
B cell activation can be initiated by the ligation of the BCR with antigen, which
results in the production of protective antibodies against potentially pathogenic invaders.
However, the specific mechanism by which antigen engagement triggers activation
processes in not yet completely understood.
The binding of specific antigen to the membrane Ig component of the BCR
initiates intracellular signaling and results in B cell activation (Harwood and Batista,
2010). The dimerization of monomeric BCR on the surface of B cells, upon stimulation
with antigen, is indicative of B cell activation. Immunofluorescence microscopy
experiments demonstrate that immunoglobulins on the surface of B cells can
spontaneously segregate to specific areas. In these areas the Ig molecules crosslink with
each other and form caps (Schreiner, 1976).
Other receptors involved in the activation of B cells include members of the Tolllike receptor (TLR) family, initially found in Drosophila melanogaster. Human
homologues to these transmembrane receptors were first described in by R. Medzhitov
(1997). This study demonstrates that TLRs induce the activation of NF-kappaB and the
expression of NF-kappaB-transcription factors. These events induce the expression of
inflammatory cytokines IL-1, IL-6 and IL-8, as well as the expression of the costimulatory molecule B7. Subsequently identified mammalian homologues were found
to recognize a series of conserved microbial products referred to as pathogen-associated
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molecular patterns (PAMPs) (Leadbetter, et al. 2002). Some of these products are
lypopolysaccharide (recognized by TLR4), microbial lipoproteins and peptidoglycans
(recognized by TLR2), and CpG DNA (recognized by TLR9) (Forchielli, 2005).
To determine whether B cell activation and antibody responses require TLR
signaling, Pasare and Medzhitov (2005) performed B cell transfer experiments. In this
study purified B cells from wildtype, MyD88 knockout, TLR4 knockout and CD40
knockout mice were transferred into mice that lack mature B cells, followed by
immunization with lipolysaccharide (LPS). MyD88 is a universal adapter protein as it is
used by most TLRs to activate the transcription factor NF-κappaB, while CD40 is
expressed on the surface of B cells and it is essential in cellular activation. The results of
this experiment suggested that the formation of germinal centers and the percentage of
germinal center B cells were diminished in mice that received TLR4 knockout or MyD88
knockout B cells. In addition to this, the activation of transcription factors involved in B
cell activation was significantly impaired in mice that receive these knockout cells. The
authors concluded that TLRs expressed on B cells have a direct role in B-cell activation.
Studies have shown that synchronized signaling through BCR and TLRs
augments expression of NF-kappaB, and enhances B cell activation, proliferation and
differentiation. Other costimulatory molecules involved in the activation of B cells are
CD40 and B7. As mentioned before, CD40 assists in the activation, proliferation,
differentiation, survival and generation of memory B cells (Jain, 2011).
To test if B cell activation can occur independently of BCR, S. Jain (2011)
stimulated resting B cells through TLR2 and CD40, both molecules crucial for innate and
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adaptive immunity. The results of this study demonstrated that the combination of
stimuli through these two receptors augmented the activation, proliferation and
differentiation of B cells.
The up-regulation of expression of the B7 family of molecules has been
considered to be the primary reason for this functional conversion of activated B cells.
Using different stimuli, Ding and Shevach, (1996) demonstrated that activated B cells
expressed comparable levels of many of the known counter-receptors for costimulation
and intercellular adhesion (B7-1, 87-2, HSA, ICAM-l). They also demonstrated that
activation of B cells via CD40, and to a lesser extent with LPS, induced potent B7
expression. This was confirmed by Yang and Wilson (1996), who administrated CD40Ldeficient mice with an activating antibody to CD40. This experiment resulted in the
increased expression of B7 on spleen cells.
Thus far, the evidence collected in different studies indicates a correlation in
innate and adaptive immune components that results in modulating the functions of B
cells. To take it one step further, S. Jain (2013) asked if the simultaneous stimulation of
TLR2 and costimulatory molecule, B7 results in the activation of resting B cells. As a
result, it was found that these B cells exhibited a significant level of activation and
proliferation. The study concluded that signaling of TLRs in conjunction with
costimulatory molecules help in strengthen humoral immune responses.
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B CELL MIGRATION VIA A CHEMOKINE GRADIENT
The working model for B cell development in the Knight Lab proposes that
resting B cells leave the BM approximately 2 days after birth and enter GALT. Once in
GALT the cells follow a chemokine gradient to the FAE, where the chemokine CCL20
(ligand to CCR6) is expressed, presumably by epithelial cells. To this day it has not been
verified if a specific process occurs to B cells in the FAE. However, it is believed that in
this region B cells may encounter bacteria that pass through M cells. Pape (2007)
demonstrated by tracking a fluorescent antigen that small antigen can diffuse into the
follicle, where is later acquired by resting B cells. This process occurs without dendritic
cell (DC) or T cell help. However, it is also possible that DCs located in the FAE capture
bacterial molecules from the lumen and ‘show’ them to B cells. These events
presumably provide the B cells with signals that may lead to their activation and
relocation to other regions of the follicle.
According to the Knight Lab working model, the B cells expressing CXCR5
migrate next to the follicular dendritic cell (FDC) zone, where stromal cells and FDCs
express the chemokine CXCL13 (Gunn, 1998). After receiving additional stimulatory
signals from FDCs, and possibly also from bacteria, the cells migrate to the T cell areas,
attracted to CCL21, a chemokine secreted by stromal cells which is also the ligand for
CCR7 (Legler, 1998). Finally, the B cells migrate to the basolateral end of the follicular
area where CXCL12, the ligand for CXCR4, is expressed. Here the cells proliferate and
the Ig genes undergo somatic diversification. This model is relevant to understanding the
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mechanism by which bacteria from the intestines of rabbits provide signals for the
activation and migration of B cells in GALT.
Chemokines are small secreted proteins that serve as critical extracellular
mediators of cell migration, particularly in the immune system. These chemoattractants
can mediate selective recruitment of particular cell types evident in certain tissues
(Comerford and McColl, 2011). Inflammatory chemokines are expressed by circulating
leukocytes and other cells only upon activation, whereas homeostatic chemokines are
constitutively expressed (Allen, 2007).

CONCLUSION
The current working model of B cell development in rabbit was derived mainly
from studies designed to understanding the mechanism and site(s) for B cell development
and activation, and the generation of the antibody repertoire. Although it has been
demonstrated that bacteria plays a central role in the above mentioned processes as well
as in germinal center formation, the specific mechanism is not yet known.
For many years the Knight Lab has focused on experiments designed to identify
the bacterial molecule(s) that drives the activation and migration of B cells in the GALT
of rabbits. In this thesis document I will give details about the strategies I used to gain
answers to some of these questions.

CHAPTER TWO
MATERIALS AND METHODS

Bacteria sorting by fluorescence-activated cell sorting (FACS)
One 4 week old rabbit from the colony maintained by K. L. Knight at Loyola
University Chicago, was sacrificed and its appendix dissected. The contents were
centrifuged to remove debris and fecal material. The supernatant optical density
(OD600nm ) was measured to estimate the concentration of bacteria (OD600nm = 0.985).
The supernatant was stained in the cold for 1 hour with 10µg/mL biotinylated a+FvIg,
biotinylated a-FvIg, and biotinylated Fcγ (negative control). After washing, the cells
were stained with 1µg/mL APC conjugated to Streptavidin. Bacterial cells were sorted
by FACS Aria cell sorter, located at the FACS Facility, Loyola University.

16sRNA sequencing
Bacterial isolates from the intestine of rabbits were grown in 5% sheep blood agar
plates. One colony was picked, re-suspended in 5mL Luria broth (LB) and grown by
agitation for 4 hours at 37°C. Genomic DNA (gDNA) was extracted as follows: 1mL of
each bacterial sample was centrifuged at 4000rpm for 5 minutes, and the pellets re-
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suspended in 0.85% NaCl solution. The samples were centrifuged again, re-suspended in
1mL 1X TE buffer (10 mM Tris-Cl, pH 7.5, 1 mM EDTA), and treated with 10µL
Proteinase K (10mg/mL). The samples were frozen for 1 hour at -80°C; digested for 1
hour at 60°C; and boiled for 15 minutes at 95°C. A volume of 0.5mL phenol-chloroform
(1:1) was next added to the tubes containing 0.5mL of the bacterial DNA solutions, and
mixed gently for 5 minutes. The tubes were centrifuged at 10,000rpm for 10 minutes at
room temperature, and the aqueous phase transferred into new labeled tubes. Next, 3M
NaOAc (1/10th of total volume) and 100% EtOH (3 volumes) were added to each tube.
The tubes were placed at -80°C for 1 hour, and then centrifuged at 13,000rpm for
15minutes. The pellet was air-dried and finally re-suspended in 20µL dH2O.
An internal segment of the16sRNA region, size 1.5kb, was amplified from the
gDNA by Polymerase chain reaction (PCR) using internal primers P6 and P7 (Table 1),
and run on a 40% polyacrylamide gel to make sure the correct gene segment was
amplified. The samples containing the correct amplified gene were run in a 1% agarose
gel. The 1.5kb DNA bands containing the amplified 16sRNA region were cut out of the
gel, placed in clean eppendorf tubes and solubilized in 6M NaI. The tubes were incubate
at 68°C for 10 minutes or until the agarose was melted. The DNA was run through a
Wizard PCR resin column with a filter, and then washed with 6mL 80% isopropannol.
The DNA solution collected in the filter was centrifuged at 12,000rpm for 2min, the filter
placed in a clean tube, and the DNA fragment eluted with 20µL of dH2O.
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The 1.5kb DNA segment was ligated into the pGMT-EZ (2746bp) vector and
incubated overnight at 16°C. Competent E. coli cells (DH10B) were then transformed
with the vector containing the 1.5kb insert using electroporation (Cell Porator®, Gibco
BRL). The cells were plated on LB-Ampicillin plates coated with 20µL IPTG and 50µL
X-Gal for blue/white screening, and incubated at 37°C for 18 hours.
The plasmid extraction was performed by Super Quick assay as follows: white
colonies were picked from each plate and grown in 5mL LB-Ampicillin for 18 hours at
37°C. Microcentrifuge tubes were loaded with 200µL of the cultures and centrifuged at
12,500rpm for 3minutes. The pellet was re-suspended in 50µL 10% Lysozyme; boiled
for 3 minutes and spun again for10 minutes. The supernatants were transferred into clean
tubes and 40µL isopropanol was added. This mixture was centrifuge at 12,500rpm for
30minutes at 4°C, and the pellet was left to air-dry. The insert was digested from the
pGMT-EZ vector with the restriction enzyme EcoRI. The digested samples were loaded
onto 1% agarose gels; run for 1 hour; and visualized to identify the samples that
contained the correct size vector and insert.
A Wizard® Miniprep was used to purify the DNA from the correct samples. This
was done by centrifuging the remainder of the culture of each sample at 3,000rpm for
10min. The pellets were re-suspended in 400µL of re-suspension solution, followed by
400µL of lysis solution and shaken immediately. After 5 minutes, 400µL of
neutralization solution was added and the tubes were agitated immediately. This mixture
was next spun two times at 3,000rpm for 10 and 5 minutes, and the supernatant
transferred into clean tubes. The supernatants were run through a Wizard resin column
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with a filter, and the DNA solution collected in the filters was centrifuged at 12,000rpm
for 2min. The filters were placed on a clean tube, and the DNA fragment eluted with
100µL of dH2O. The purified DNA was next sequenced. Basic Local Alignment Search
Tool (BLAST) was used to check for sequence matches.

Exhaustion Sporulation
Bacillus anthracis isolated from the appendix of a rabbit (Severson, 2010) was
grown in 5% sheep blood tryptic soy agar overnight at 37°C. One to three colonies were
picked and grown for 48 hours in 10mL Difco Sporulation Medium (DSM) with
supplements (1.2% MgSO4; 10% KCl; 1N NaOH; 1M Ca (NO3)2; 0.01M MnCl2; 1mM
FeSO4; pH~7). The culture was next diluted 1:5 in DSM medium and allowed to grow
for 4 to 5 hours (stationary phase of culture). The liquid culture was diluted a second
time at a 1:5 ratio (log phase of culture) and allowed to grow for 24 hours. The culture
was centrifuged at 10,000g for 10min at 4°C (RC5C Sorvall Instruments Centrifuge; SS34 rotor), and the pellet was re-suspended in cold autoclaved distilled H2O. This was
repeated 4 more times. The purified preparation of spores was stored in water at 4°C.

Immuno-dot Blot Analyses
A dot blot apparatus was assembled, packed with filter paper and a nitrocellulose
membrane (0.2µm Trans Blot Transfer Medium), and connected to a vacuum. Freshly
purified wildtype or Δbcla B. anthracis spores were either sonicated in 1X PBS, or lysed
in loading buffer (SDS; 10% 2-Mercaptoethanol). The lysates were further diluted 1:6 in
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TBST (Tris buffered saline; Tween 20) buffer, and centrifuged at maximum velocity for
10minutes in the cold to discard unwanted molecules. The nitrocellulose membrane was
loaded with 50µL of sonicated or lysed spores, and the vacuum was applied to pull down
the proteins into the membrane. The blot was blocked with 5% non-fat milk in TBST
overnight. The next day the membrane was probed with 10µg/mL a+Fv-Ig or Fcγ,
followed by 0.8µg/mL HRP conjugated donkey anti-rabbit IgG (H+L) (1:2000). The
immune-blots were developed with Pierce® ECL Western Blotting Substrate (Thermo
scientific Lot# NI172907).

Native gel electrophoresis
A 6% native gel was prepared in the absence of SDS. A 10 ml separating gel
mixture was polymerized for 1 hour by mixing 40% acrylamide:bis solution (37.5:1),
separating gel buffer (36.3g Tris, 150mL dH2O, pH 8.8), 50% glycerol, dH2O, 10%
ammonium persulfate and TEMED (N, N, N', N'-tetramethyl-ethylenediamine). The
stacking gel solution was prepared by mixing 40% acrylamide:bis solution (37.5:1),
stacking gel buffer (15.1g Tris, 40mL dH2O, pH 6.8), 10% ammonium persulfate and
TEMED.
Wildtype or mutant Δbcla B. anthracis spores were dissolved in 2X sample buffer
(stacking gel buffer, 20% glycerol, 0.02% Bromophenol Blue, 5% Bromophenol Blue
and deionized H2O) and loaded into the gel. The samples were run at 150V and later
transferred overnight into a nitrocellulose membrane. The blot was probed with
40µg/mL a+FvIg, followed by 0.8µg/mL HRP conjugated donkey anti-rabbit IgG (H+L)
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(1:2000). The immune-blot was developed with Pierce® ECL Western Blotting Substrate
(Thermo scientific Lot# NI172907).

Immunofluorescence microscopy
Newly obtained Δbcla B. anthracis spores - no older than one week - were
washed 3 times with cold autoclaved water, and diluted at a ratio of 1:6. Superfrost® Plus
slides (VWR Lot# 27999) were coated with poly-L-lysine solution (Sigma-Aldrich Lot#
127K4348), washed 2 times with water, and left to dry overnight. A small aliquot (20µL)
of the spores was added to a circular area previously outlined on the surface of the slides
using a Super PAP Pen (Immunotech, Beckman Coulter). After 5 minutes of incubation
the slides were washed by submersion 3 times in 1X PBS, and air-dried for 30 minutes.
The samples were re-hydrated for 5 minutes and washed 2 more times in 1X PBS. The
sample were next blocked with 2.5% BSA (Hyclone® Thermo Scientific Lot#
110913941E) diluted in 1X PBS for 30 minutes. The samples were stained first with
20µg/mL a+FvIg or a-FvIg for 1 hour, and then stained with 12.5µg/mL mouse anti-rabbit
IgG (BD PharmingenTM Lot# 56990) for 30 minutes, followed by 10µg/mL Alexa
Fluor® 568 goat anti-mouse IgG1 (γ1) (Invitrogen Lot# 53900A) for 30 minutes. The
spores were washed 3 times after the antibody incubations. The sample area was covered
with a coverslip after receiving one drop of PermaFluor aqueous mounting media
(Thermo Scientific Lot# FM100602). The spores were visualized using a phase-contrast
objective on a Leica DM IRB fluorescence miscroscope equipped with MagnaFire CCD
camera.
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Biotinylation of proteins
An analytical scale was used to weight enough Biotin (EZ-Link Sulfo-NHS-LCBiotin Product, No. 21335 Thermo Scientific) to have a final concentration of 2mg/mL
Biotin in 1X PBS. The Biotin was added to a tube containing 100µg/mL of a+Fv or a-Fv.
After mixing well, the proteins were left at room temperature for 1 hour. The proteins
were next dialyzed in a 0.1-0.5mL dialysis cassette (Slide-A-Lyzer 10K Product No.
66383; Thermo scientific) in 1X PBS overnight to eliminate excess Biotin. The 1X PBS
buffer was changed 4 times. The biotinylated proteins were collected the next day and
their O.D. was measured.

Immunoprecipitation
Bacillus pumilus, Propionibacter acnes or Bacillus thuringiensis grown in LB or
5% sheep blood agar plates in modified anaerobic chambers (OXOID, Model G, code
HP0031A. GasPakTM EZ Gas Generating Container Systems, BD Lot # 2031360) were
washed and re-suspended in 1X PBS. Bacteria were next labeled with 2mg/mL EZ-Link
Sulfo-NHS-LC-Biotin for 1 hour at 4°C. After washing with 0.2M Tris in 1X PBS, the
labeled bacteria were re-suspended in lysis buffer (1.5M NaCl; 1% NP-40; 1% Triton X100) and incubated at 4°C for 1 hour. The lysates were centrifuged at 12,500rpm for 2
minutes, the supernatant transferred to clean tubes, and the pellets washed once with 1X
PBS to reduce the final salt. The supernatants were pre-cleared two times for 30 minutes,
each at 4°C using Protein G beads (GammaBindTM G SepharoseTM protein; GE
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Healthcare; Lot 10055876). The supernatants were pooled in clean tubes and stored at 20°C.
At the same time, 30µg/mL a+FvIg or a-FvIg molecules were conjugated for 40
minutes at 4°C to Protein G beads. In a different experiment, serum from rabbit, human
or goat (300µL) was incubated with 100µL of Protein G beads for 30 minutes at 4°C to
obtain IgG-Protein G conjugates. The biotinylated bacterial molecules were
immunoprecipitated with a+Fvg and a-FvIg molecules, or with rabbit, human or goat
serum IgG for 40 minutes at 4°C.

Western Blot
For immunoprecipitation experiments, the pellet of Protein G-beads conjugated to
either FvIg or IgG molecules was washed two times with TBST, and re-suspended in
TBST and loading buffer (4X SDS or 2X SDS; 10% 2-Mercaptoethanol). The samples
were electrophoresed on 10% SDS-polyacrylamide gels. The precipitated proteins were
transferred to Immobilon-P Transfer Membrane (Millipore, Bedford, MD) and probed
with 0.1µg/mL HRP conjugated to Streptavidin. The immune-blots were developed with
SuperSignal® West Pico Chemiluminescent Substrate (Thermo scientific Lot#
ND172889).
For B. anthracis Δbcla experiments, the spores were lysed under reducing and
non-reducing (with 2-ME or without 2-ME) conditions, and loaded on 12% SDSpolyacrylamide gels. The blots were probed with 15µg/mL a+FvIg or a-FvIg, followed by
0.8µg/mL HRP-conjugated donkey anti-rabbit IgG (H+L) (1:2000). The immune-blots
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were developed with Pierce® ECL Western blotting substrate (Thermo scientific Lot#
NI172907).

VH4 cloning
The constructs for a+FvIg (VH1a2, VHa allotype) and a-FvIg (VHy33, VHn allotype)
were originally ligated into pcDNA3.1(-) plasmids of size 5.4 kb (Severson, 2010). The
FvIg inserts contain the whole VDJ region of the heavy chain of a normal rabbit, a
(Gly4/Ser1)3 linker, a Vκ gene, and part of the Fc region (Cγ2 and Cγ3) (Fig. 1). The
plasmid containing the VHa construct was used as template to substitute its VH1 for VH4, a
rearranged gene prevalently found in VHa cells of Alicia rabbits. These two VH genes
differ only in 9 base pairs (bp).
To start the cloning process, a 115 bp product extending from framework region 3
(FR3) to the first half of the linker was amplified by polymerase chain reaction (PCR)
using primers P1 and P2 (Table 1). Simultaneously, the VH4 gene from an Alicia rabbit
that included the VH leader was amplified by PCR using primers P3 and P4 (~330bp).
The plasmid containing the VH4 construct was provided by Greg Robins, PhD. These
two PCR products were ligated after digesting their respective 3’ and 5’ regions with the
restriction enzyme SacII. The ligated product (~445bp) was PCR amplified using
primers P3 and P2, and extended from the VH leader of the VH4 gene to the first half of
the linker.
The template plasmid pcDNA3.1(-) containing the VHa construct was digested
from the VH leader to the first half of the linker using primers P3 and P2 (~445bp). This
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segment was replaced by the insert containing the VH4 gene (~445bp) by ligation.
Plasmids containing the complete constructs containing the VH4 gene were transfected
into Chinese hamster ovary (CHO) cells.

B cell transfection
A total of 250x104 cells/mL PBL-1, 55D1 or 79E cells were washed with 10mL
RPMI 1640 medium with no fetal bovine serum (FBS), and re-suspended in 1mL HEPES
buffer. The cells were mixed with 10µg pNF-κB- Luc reporting plasmid (5kb, Agilent
Technologies, provided by Dr. Chris Wiethoff, Loyola University) and 4µg pCEP4
(10kb, Invitrogen), which contains a hygromycin mammalian resistance gene. After
electroporation (Cell Porator®, Gibco BRL), the transfected cells were re-suspended in
RPMI and added to a 24-well plate. Next, 0.2 mg/mL Hygromycin B selection drug
(CALBIOCHEM®, Lot# B50706) was added to the wells and incubated for 2 days at
37°C. The cells were treated with the selection drug and monitored every 2 days in order
to find stable transfectants.
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Figure 1: Schematic of FvIg molecules containing different VH genes.
The top and center part of the figure are the FvIg constructs (a+FvIg and aFvIg) designed and developed by K. Severson (2010). The bottom part of
the figure shows the Fv molecule containing a VH4 gene. The constructs
contain the VDJ region of the heavy chain of a normal rabbit, a
(Gly4/Ser1)3 linker, a Vκ gene, and part of the Fc region (Cγ2 and Cγ3).
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Table 1: List of primers and their sequences
Primer

Name

Sequence

P1

OS-VH-SacIII

CTGCCGCGGACACGGCCACC
TATTT

P2

OA-VH-LINKER-BAM2

P3

OS-V-LDR-XHO

TGGATCCACCGCCACCTGAG
GAGACGGTGACCAG
ACTCGAGGCCGCCACCATGG
AGATT

P4

OA-VH4-FR-SACII

TGTCCGCGGCTGTCAGACTG
GTCA

P5

16sRNApan27f

AGAGTTTGATCCTGGCTCAG

P6

16sRNApan1492r

CGGTTACCTTGTTACGACTT
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Luciferase detection
Approximately 1x106 55D1 cells, transfected with an NF-κB Luciferase plasmid,
were stimulated with goat anti-rabbit IgM at 1:5, 1:10 and 1:20 dilutions, or with
sonicated B. pumilus for 20 minutes, 2 hours and 4 hours. The cells were washed at
1000rpm for 5 minutes at room temperature with 1X PBS. The pellet was re-suspended
in 100µL 1X Passive Lysis Buffer (PLB) and placed in a rocker for 15 minutes. A
volume of 25µL of cell lysate was loaded into a white 96-well plate. The lysates were
read in a Veritas Microplate Luminometer (Turner Biosystems), using a Luciferase Assay
Substrate (Promega Lot # 0000027225).

Stimulation of B cells
Rabbit stable B cell lines - PBL-1, 55D1 and 79E - were stimulated with different
molecules in the presence or absence of CD40L expressed on the surface CHO cells. The
molecules used for stimulation are as follow: goat anti-rabbit IgM (serum, Maggie) at a
1:5, 1:10 or 1:20 dilution; sonicated B. pumilus (200µL); 5µg/mL of purified
exopolysaccharide from B. subtilis (sinRtasA or sinRtasAepsH); 10µg/mL of TLR2,6
agonist Pam3CSK4 Lyophilized (InvivoGen Lot# 28-04-PMS); 10µg/mL of TLR1,2
agonist Pam2CSK4 (InvivoGen Lot# PM2-33-03); 1µg/mL LPS from Salmonella
enterica serotype enteritidis (Sigma Aldrich Lot# L7770-1MG).

CHAPTER THREE
RESULTS

ROLE OF BACTERIAL MOLECULES IN B CELL ACTIVATION AND
MIGRATION IN GALT
In rabbits, antibody diversity is generated in GALT where B cells migrate after
leaving the BM. B cells that seed GALT expand polyclonally and the primary antibody
repertoire expands. These processes require interaction of GALT with intestinal
microbiota. However, the molecular mechanism by which bacteria promote GALT
development and function is not yet fully understood.
I hypothesized that molecules of selected bacterial species in the intestine of
rabbits cause the activation of B cells and also alter the expression of chemokine
receptors, which regulates their migration in GALT. To understand the mechanism by
which commensals drive GALT reactions, I investigated the processes that lead to the
activation and migration of B cells in GALT. Using FvIg recombinant molecules, I asked
if bacterial molecules from the intestine of rabbits bind to surface Ig of B cells or to
soluble Ig. To determine whether bacteria provide signals for activation and migration, I
detected the expression of B7, a surface molecule of the Ig family expressed on
activated B cells but not on resting B cells. In addition, I detected the expression of
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chemokine receptors (CCR6, CXCR5, CCR7 and CXCR4), known to be expressed on B
cells as they move throughout the follicle.
The results of these experiments, as described below, lead me to propose that
bacterial products provide B cells with signals that may lead to their activation and
relocation to other regions of the follicle.

Binding of intestinal bacteria to FvIg
The intestinal microbiota has a role in the generation and diversification of B cells
in GALT. Serum Ig secreted from B cells of normal rabbits shows a predominant VHa
allotype over the VHn allotype. In contrast to this, Alicia mutant rabbits show at birth a
prevalence of the VHn allotype. Upon contact with the gut microbiota, the mutant rabbit
VHn B cell population stops proliferating and instead, VHa B cells expand. These events
may take place by selective expansion induced by bacteria. This is supported by the fact
that rabbits with surgically ligated appendix (germ-free) fail to develop VHa B cells
(Rhee, 2004).
The initial goal of this research was to determine if the repertoire expansion from
VHn to VHa B cells results from interactions between a putative bacterial superantigen
with VHa B cells in the GALT of Alicia rabbits. To test this original hypothesis I used
biotinylated a+FvIg (VHa) and a-FvIg (VHn) recombinant proteins to isolate bacterial
species from the intestine of rabbits. Bacteria binding to the FvIg were detected with
APC conjugated Streptavidin. Figure 2 shows three groups of bacteria that bind to either
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a+FvIg (blue events), a-FvIg (green events), or to both FvIg simultaneously (purple
events). Biotinylated Fcγ was used as negative control. The P1 population displayed in
the left side panel did not bind to Fcγ and was used for the subsequent sorting. Only
bacteria binding to a+FvIg and a-FvIg were used for later experiments. Bacteria binding
to both FvIg at the same time (double population; purple events) were dismissed.
I initially obtained 12 bacterial isolates from the intestines of rabbits that grew in
media, and were later identified by 16sRNA sequencing. Table 2 displays the names of
each species, their gram stain, and their ability to produce spores. This table also shows
whether the species were initially sorted with a+FvIg or a-FvIg, and if they grew in
aerobic or anaerobic conditions. To test if the binding profile of these bacteria to the
FvIg molecules was reproducible, I re-screened the isolates by FACS using the FvIgs a
minimum of three times. The results of the re-screening experiments showed that most
of the bacterial species no longer bound to the FvIgs (data not shown). Only 3 species B. thuringiensis, B. pumilus and P. acnes - retained their binding activity to the FvIg
molecules. These 3 organisms were further tested.
Figure 3 shows two independent re-screenings of B. thuringiensis using FvIgs.
This species was initially sorted with a+FvIg. On the first experiment (Fig 3A) I was able
to reproduce the initial sorting profile: B. thuringiensis bound to a+FvIg (green
histogram) but not to a-FvIg (purple histogram). However, in a later experiment, this
specie did not bind to either one of the FvIgs (Fig. 3B).
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Figure 2: Flow cytometric analysis of bacteria from the intestine of rabbits
bound to FvIg. The contents of the intestine of rabbits were centrifuged to
remove debris and fecal material. The supernatant was stained with 10µg/mL Fcγ
biotinylated a+FvIg and a-FvIg. The gated P1 population (left panel) did not bind
to the negative control Fcγ. The right hand panel shows cells binding to a+FvIg
(blue dots); cells binding to a-FvIg (green dots); and cells binding both Fv (purple
dots). The cells were detected with APC conjugated Streptavidin, and sorted by
FACS Aria cell sorter.
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Table 2: Characteristics of isolated bacterial species and their sorting profile

Specie

Gram
stain

Spore
former

Sorted

Culture
condition

Neisseria subflava

negative

no

a+FvIg

aerobic

Caldimonas manganoxidans

negative

no

a+FvIg

aerobic

Propionibacter acnes

positive

no

a+FvIg

aerobic

Bacillus thuringiensis

positive

yes

a+FvIg

aerobic

Neisseria subflava u37

negative

no

a-FvIg

aerobic

Neisseria flavescens

negative

no

a-FvIg

aerobic

Propionibacterium acnes

positive

no

a+FvIg

anaerobic

Bacillus aerophilus 28K

positive

yes

a+FvIg

anaerobic

Bacillus pumilus attc7061

positive

yes

a+FvIg

anaerobic

Bacillus safensis

positive

yes

a-FvIg

anaerobic

Propionibacterium acnes

positive

no

a-FvIg

anaerobic

Neisseria flavescens N155

negative

no

a-FvIg

anaerobic

40
Since I was able to grow B. thuringiensis in both aerobic and anaerobic
conditions, I tested if this factor would influence binding to FvIgs. The results obtained
in Figure 4 suggested that this was correct. When cultured in liquid broth under aerobic
conditions, B. thuringiensis lost its ability to bind to the FvIg molecules (Fig. 4C).
However, when grown in liquid broth under anaerobic conditions most of the cells bound
to a+FvIg but not a-FvIg (Fig. 4 D). Strikingly, I observed that this organism can also
bind to a-FvIg (Fig. 4, A&B), contradicting the initial sorting and the re-screening results
shown in Figure 3.
I performed similar re-screens on B. pumilus, which was initially sorted after
binding to a+FvIg, and grew exclusively under anaerobic conditions. To test if this
organism would replicate its initial binding to a+FvIg, I performed independent
experiments using the same conditions. I initially confirmed that B. pumilus binds a+FvIg
(green histogram) but not to a-FvIg (purple histogram) (Fig. 5A). However, a latter
experiment (Fig. 5B) demonstrated that this species can also bind to a-FvIg (green
histogram) but not to a+FvIg (blue histogram) or to Fcγ (brown histogram). Since I had
previously observed that the condition of the culture may influence the binding of B.
thuringiensis to FvIgs (Fig. 4), I tested if the same was the case for B. pumilus. I cultured
the cells on blood agar plates or in a broth under anaerobic conditions and stained them
with FvIgs. I found that under both growth conditions, over 66% B. pumilus cells bound
a+FvIg (Fig. 6, A&B).
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Figure 3: Flow cytometric analysis of Bacillus thuringiensis binding to FvIg.
Two different experiments, two months apart: A) former experiment using cells
from an anaerobic blood agar plate. Bacteria were stained with 20µg/mL FITCconjugated a+FvIg (green), FITC-conjugated a-FvIg (purple), or left unstained
(gray). B) Later experiment using cells from an aerobic blood agar plate.
Bacteria were stained with 20µg/mL FITC-conjugated a+FvIg (green), FITCconjugated a-FvIg (blue), FITC-conjugated Fcγ (brown), or left unstained (red).
The analysis was performed in a LSR FortessaTM flow cytometer.
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Figure 4: Flow cytometric analysis of Bacillus thuringiensis binding to FvIg.
Bacteria cells were cultured under different conditions: A) anaerobic blood agar
plate, B) aerobic blood agar, C) aerobic broth and D) anaerobic broth. Bacteria
were stained with 20µg/mL APC-conjugated a+FvIg or PE-conjugated Cy7-aFvIg. Each experiment was performed independently over the course of 2 weeks.
The analysis was performed in a LSR FortessaTM flow cytometer.
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Figure 5: Flow cytometric analysis of Bacillus pumilus binding to FvIg. Two
different experiments, two months apart: A) First experiment using cells from an
anaerobic blood agar plate. Bacteria were stained with 20µg/mL FITCconjugated a+FvIg (green line), FITC-conjugated a-FvIg (purple line), or left
unstained (gray line). B) Second experiment using cells from an anaerobic blood
agar plate. Bacteria were stained with 20µg/mL FITC-conjugated a+FvIg (green
line), FITC-conjugated a-FvIg (blue line), FITC-conjugated Fcγ (brown line), or
left unstained (red line). The analysis was performed in a LSR FortessaTM flow
cytometer.
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Figure 6: Flow cytometric analysis of Bacillus pumilus binding to FvIg.
Bacterial cells were cultured under different conditions: A) anaerobic blood agar
plate or B) anaerobic broth. Bacteria were stained with 20µg/mL APCconjugated a+FvIg or PE-conjugated Cy7-a-FvIg. Each experiment was
performed independently over the course of 2 weeks. The analysis was performed
in a LSR FortessaTM flow cytometer.
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The third organism of interest P. acnes was initially sorted with a-FvIg and grew
exclusively under anaerobic conditions. Further experiments showed that this organism,
re-screened with a+FvIg (Fig. 7, A&B), did not bind to a-FvIg. In both experiments, over
57% of the cultured cells bound to a+FvIg. However, at least one independent
experiment showed that P. acnes did not bind to either FvIg molecule (Fig 8).
The data collected in these experiments showed that bacterial molecules can bind
Ig, but that the binding of bacteria from the intestines of rabbits to FvIg varies with
culture conditions. In addition, I concluded that none of the isolated bacterial species
bind exclusively to either a+FvIg or a-FvIg.

Detection of bacterial molecules binding to FvIg
A previous study in the Knight Lab suggested an interaction between Bacillus
spores and Igs. In this study, K. Severson (2010) observed that both FvIg and rabbit IgM
bound robustly to B. anthracis Δbcla mutant spores. This mutant strain lacks spore
surface hair-like projections, and has therefore, an exposed exosporium. The study goes
on to suggest that the FvIgs bind to epitopes on the exosporium. To confirm this
hypothesis, they tested a B. anthracis mutant strain lacking the exosporium (ΔcotO) and
found, by Western blot, that FvIg would bind to a molecule of ~25kDa from wildtype
(WT spores); however, FvIg did not bind to the mutant lacking the exosporium. The
study identified the ~25kDa molecule as ExsK, which is known to be present in the
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Figure 7: Flow cytometric analysis of Propionibacter acnes binding to FvIg.
Bacteria cells were cultured under different conditions: A) aerobic blood agar
plate, B) anaerobic blood agar plate. Bacteria were stained with 20µg/mL APCconjugated a+FvIg or PE-Cy7-conjugated a-FvIg. Each experiment was
performed independently over the course of 2 weeks. The analysis was
performed in a LSR FortessaTM flow cytometer.
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Figure 8: Flow cytometric analysis of Propionibacter acnes binding to FvIg.
Bacteria from an anaerobic blood agar plate were stained with 20µg/mL FITCconjugated a+FvIg (green line), FITC-conjugated a-FvIg (blue line), FITCconjugated Fcγ (brown line), or left unstained (red line). The analysis was
performed in a LSR FortessaTM flow cytometer.
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exosporium of spores. It was also concluded that both FvIg and rabbit IgM bind to ExsK
on the surface of B. anthracis (Severson, 2010). Therefore, I reasoned that B. anthracis
Δbcla was an appropriate positive control for my binding experiments using FvIgs.

Testing Δbcla control by Western blot, Dot blot and Native gel electrophoresis
I showed by flow cytometry that bacteria from the intestines of rabbits bind to
FvIgs. However, I did not know if one or more molecules are binding to these
recombinant molecules. Moreover, I did not know the identity of such molecule(s). To
detect the bacterial molecule(s) binding to the FvIgs, I made bacterial lysates and
performed Western blot assays using FvIgs.
The first logical step was to determine if the positive control B. anthracis Δbcla
would work in my system. This mutant was shown to bind to the FvIgs by flow
cytometry experiments and by immuno-fluorescence microscopy experiments, but it had
not yet been tested by western blot. I made lysates of purified WT and mutant B.
anthracis spores using SDS with 2-ME and performed a western blot. I probed the
bacterial samples with either a+FvIg or a-FvIg. If B. anthracis ExsK molecule binds to
FvIgs, then by using the Δbcla mutant, which has an exposed exosporium, I would expect
to find bands of about 12kDa and 25kDa, the sizes of the ExsK molecule. The goal of
this experiment was to reproduce the results previously obtained in the Knight Lab, this
time using western blot analysis.
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Figure 9A shows a western blot of proteins from WT and Δbcla spores prepared
under reducing and non-reducing conditions. The blot was probed with a+FvIg. I
observed faint high molecular weight proteins (lines 3 and 4) from the Δbcla mutant
spores, but was unable to observe 12kDa or 25kDa bands. I also did not detect proteins
in the WT spore lysate samples (lines 1 and 2). To determine if the ExsK protein was
instead binding to a-FvIg, I probed a blot with this recombinant molecule (Fig. 9B) and
found similar results to those obtained when probing with a+FvIg. I observed a few high
molecular weight proteins (lines 3 and 4) in the Δbcla mutant spore samples, but I was
unable to observe 12kDa or 25kDa bands. Further, I also did not detect proteins in the
WT spore lysate samples (lines 1 and 2).
The results shown in Figure 9 are a representation of several unsuccessful
experiments designed to detect ExsK by western blot analysis. One possibility to explain
this is that ExsK was not able to bind FvIg molecules when tested in a
denatured/unfolded state. To address this possibility, I designed and performed Dot blot
assays. This approach gave me a tool to test simultaneously reduced/denatured and
unreduced/native B. anthracis spore samples.
The top half of Figure 10 shows WT and Δbcla spore lysates that were reduced
using conventional SDS loading buffer in the presence of 2-ME. The lower half of both
panels show WT and Δbcla spore lysates that were previously sonicated in 1X PBS and
kept in an unreduced/non-denatured state. The blots were probed with a+FvIg (Fig. 10A)
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Figure 9: Western blot analysis of B. anthracis spores binding to FvIg.
Wildtype or Δbcla mutant spores were lysed under reduced or non-reduced (with
2-ME or without 2-ME) conditions, and loaded on a 12% SDS-polyacrylamide
gel. The blots were probed with A) 15µg/mL a+FvIg or B) 15µg/mL a-FvIg. The
FvIg molecules were detected with 0.8µg/mL HRP-conjugated Donkey antiRabbit IgG (H+L) (1:2000).
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or Fcγ (Fig. 10B), and developed using the conventional western blot method. Proteins
were only detected in the sonicated WT and Δbcla samples by a+FvIg (Fig. 10A, black
dots) but not by Fcγ.
To further test whether the native state of ExsK determines its binding to FvIg I
designed and performed native gel electrophoresis experiments. In these experiments the
gel and electrophoresis solutions were prepared without SDS and without the reducing
agent dithiothreitol (DTT), used in standard SDS-PAGE. In this assay the protein of
interest retains its folded conformation. However, after several attempts to detect ExsK
with FvIgs under native conditions, I did not have definitive results that would confirm
that the native state of ExsK determines binding to FvIg. One of such attempts is
depicted in Figure 11. Wildtype and B. anthracis Δbcla spores were dissolved in nondenaturing conditions and loaded on a 6% native gel. The blots were probed with a+FvIg
(left panel), a-FvIg (center panel), or Fcγ (right panel) as negative control. I was not able
to detect Exsk or any other spore protein in any of the blots.

Immunofluorescence of B. anthracis spores
Previous immunofluorescence experiments performed in the Knight Lab
demonstrated that B. anthracis Δbcla mutant spores, but not to WT spores, bind to FvIg
and IgM. These studies also suggested that this binding is mediated by the ExsK protein
exposed on the surface of the Δbcla spores. Additionally, I have gathered evidence that
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Figure 10: Dot blot analysis of B. anthracis spores binding to FvIg. Wildtype
or Δbcla mutant spores were lysed under reducing conditions (w/ 2-ME) or
prepared under non-reducing native conditions (sonication in 1X PBS). The
samples were loaded on a 0.2µm nitrocellulose membrane and probed with A)
10µg/mL a+FvIg or B) Fcγ. The proteins were detected with 0.8µg/mL HRP
conjugated donkey anti-rabbit IgG (H+L) (1:2000).
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Figure 11: Native gel electrophoresis of B. anthracis spores binding to FvIg.
Wildtype or Δbcla mutant spores were dissolved under native conditions. The
samples were loaded on a 6% PAGE gel, transferred into a nitrocellulose blot, and
probed with 40µg/mL a+FvIg (left), a+FvIg (center), or Fcγ (right). The proteins
were detected with 0.8µg/mL HRP conjugated donkey anti-rabbit IgG (H+L)
(1:2000).

54
suggest that ExsK or other proteins involved in binding to FvIgs do so only when their
native structure is intact (Fig. 10). However, I did not confirm this idea by native gel
electrophoresis experiments (Fig. 11). One possibility is that due to human mistake, the
spores I used for my western blot experiments (Figures 9, 10 & 11) were actually not B.
anthracis Δbcla, but rather spores from other species. To verify in some measure that I
was using the correct B. anthracis spores, I performed immunofluorescence microscopy
experiments. I reasoned that if the spores were not B. anthracis Δbcla, then I would not
be able to reproduce the results previously obtained in the Knight Lab, in which B.
anthracis Δbcla mutant spores, but not to WT spores, bound to FvIg and IgM.
I coated microscopy slides with B. anthracis WT or with what I thought was
Δbcla spores, and probed them with a+FvIg (Figure 12, A&C) or the negative control, Fcγ
(Figure 12, B&D). I expected to observe the putative Δbcla spores binding to a+FvIg but
not to Fcγ. In addition, I expected to find that WT spores do not bind to either a+FvIg or
Fcγ. The top row of Figure 12 shows phase-contrast images of the spores, while the
bottom row shows fluorescence images of the B. anthracis spores. The images presented
in this figure were captured using the same magnification.
The results of this experiment show that the presumed Δbcla spores bind to
a+FvIg but not to Fcγ (Fig. 12, A&B, bottom). I also observed that WT spores did not
bind to either a+FvIg or to Fcγ (Fig. 12, C&D, bottom). Overall, my results indicate that
the putative Δbcla spores, but not to WT spores, bind to FvIg. These results do not
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confirm the identity of the spores as Δbcla B. anthracis; however, it shows that these
‘mystery’ spores bind to FvIg in an identical manner to Δbcla B. anthracis spores.

Immunoprecipitation of bacterial molecules
As described above, the attempts to detect Ig-binding molecules in intestinal
bacteria or spores by western blot were ineffective. To further test for such Ig-binding
molecules, I performed immunoprecipitation experiments, which would give me the
means to isolate particular protein(s) from a bacterial lysate containing numerous
different proteins.
My approach was to first, biotinylate the surface of bacterial species isolated
from the intestine of rabbits (Table 2). For this experiment I used the bacteria of interest
B. thuringiensis, B. pumilus and P. acnes. This was followed by lysing the cells in a high
salt, mild detergent buffer (1.5M NaCl; 1% NP-40; 1% Triton X-100); the lysates were
incubated with FvIg conjugated to Protein G beads, and the precipitates were loaded onto
an SDS-polyacrylamide gel, and a western blot analysis was performed. If bacterial
molecules bind to FvIg, then I would expect to precipitate such molecule(s) with FvIg.
The resulting western blot revealed a ~20kDa bacterial molecule from B. pumilus
and P. acnes that immunoprecipitated with both a+FvIg and a-FvIg (lines 1 to 4, Figure
13). Binding of this molecule to a-FvIg was considerably more abundant than binding to
a+FvIg. Additionally, I observed that several molecules from B. thuringiensis
precipitated with both a+FvIg and a-FvIg (lines 5 and 6). These results suggest that
surface molecule(s) from intestinal bacteria of rabbits can bind to FvIg.

56
Immunoprecipitation of bacterial molecules with IgG from serum of diverse species
The expansion of B cells and somatic diversification of Ig genes in GALT is
polyclonal, and occurs in an antigen- and T cell-independent mechanism (Pospisil and
Mage, 1998). The process of somatic diversification requires interaction of GALT with
intestinal microbiota (Rhee, et al., 2004). At least one study suggests that B cells can be
polyclonally stimulated in vitro by bacteria through the engagement of IgM by B cell
superantigens (Severson, 2010).
These data led me to initially hypothesize that a bacterial superantigen binds to
IgM on the surface of B cells, independent of their antigen specificity. With the purpose
of testing this hypothesis, I was able to isolate bacteria from the intestine of rabbits using
FvIgs (Table 2). In addition, I successfully identified a ~20kDa bacterial molecule from
intestinal bacteria that immunoprecipitated with FvIgs (Fig. 13). These data indicated
that bacterial molecules can bind surface Ig and supported the idea that in the FAE,
bacteria provide B cells with signals that may lead to their activation.
To further test if bacterial molecules can bind to the surface Ig of B cell, I
performed additional immunoprecipitation assays and tested if biotinylated B. pumilus
surface proteins can bind serum IgG. Bacterial cell lysates were incubated with serum
IgG from rabbit, human or goat conjugated to Protein G beads. The immunoprecipitation
of bacterial molecules was detected by western blot. If bacterial molecules bind to B cell
surface Ig to provide signals that may stimulate B cell activation, then I expected that
such molecules would immunoprecipitate with serum Igs.
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Figure 12: Immuno-fluorescence microscopy of B. anthracis spores. Bacillus
anthracis Δbcla spores (A and B) or WT spores (C and D) were fixed onto slides
coated with poly-L-lysine solution. The top row shows phase contrast images of
the spores. The bottom row shows immuno-stained spores. The samples were
stained with 20µg/mL a+FvIg (A and C) or Fcγ (B and D), followed by 2.5µg/mL
mouse anti-rabbit IgG. The spores were detected with 10µg/mL DyLight488conjugated goat anti-mouse (Fab), and visualized using a fluorescence
miscroscope equipped with MagnaFire CCD camera. The same magnification
was used in each case.

58

Figure 13: Immunoprecipitation of bacterial molecules with FvIg. B.
pumilus, P. acnes and B. thuringiensis were labeled with 2mg/mL of EZ-Link
Sulfo-NHS-LC-Biotin. Bacteria were washed with 0.2M Tris in 1X PBS and
lysed in lysis buffer (1.5M NaCl; 1% NP-40; 1% Triton X-100). The biotinylated
bacterial molecules were immunoprecipitated with 30µg/mL a+FvIg and a-FvIg
molecules that had been conjugated to Protein G beads. The precipitates were
loaded on an SDS-polyacrylamide gel and western blot was performed. The
proteins were detected with HRP-conjugated Streptavidin.
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The results of two independent experiments are shown in Figure 14 A and B. In
both experiments I observed that not one, but several, bacterial molecules bound to
rabbit, human and goat IgG. In addition, I detected slight differences in the size and
abundance of bacterial molecules that bind to IgG from these three mammalian species.
These results provide further evidence that bacterial molecules can bind Ig and they are
consistent with the hypothesis that bacterial molecules can activate rabbit B cells through
surface Ig.

Intestinal bacteria bind to Ig
To confirm that bacteria isolated from the rabbit intestine bind to whole Ig, I
tested vegetative cells by flow cytometry. I had successfully shown that proteins of B.
pumilus immunoprecipitate with FvIgs (Fig. 13), and I hypothesized they would also bind
to intact Igs. My source of Igs was rabbit serum.
I incubated vegetative B. pumilus cells with normal serum from rabbit, and
detected the binding profiles of these bacteria to IgA, IgG or IgM (Fig. 15). The results
show that B. pumilus binds robustly to IgM (green histogram) and IgG (blue histogram),
and less strongly to IgA (brown histogram). This experiment demonstrates that bacteria
from the intestine of rabbits can bind to intact Igs. These data support the idea that in the
FAE, bacteria or bacterial products may bind to B cells through surface Ig.
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Figure 14: Western blot analysis of B. pumilus surface molecules
immunoprecipitated with serum IgG. B. pumilus vegetative cells were
biotinylated with 2mg/mL EZ-Link Sulfo-NHS-LC-Biotin. The cells were lysed
in lysis buffer (1.5M NaCl; 1% NP-40; 1% Triton X-100). The biotinylated
bacterial molecules were immunoprecipitated with rabbit, human or goat serum
IgG conjugated to Protein G beads. The proteins were detected with HRP
conjugated Streptavidin.
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Figure 15: Flow cytometric analysis of B. pumilus binding to rabbit serum Ig.
B. pumilus vegetative cells were incubated with normal rabbit serum. The cells
were stained with biotinylated 367 anti-IgM mAb (1:200) (green), 1µg/mL
biotinylated anti-Rb IgA (brown), or 3.9µg/mL biotinylated goat α-rabbit Fcγ
(blue). Binding activity was detected with Strepavidin-conjugated APC.
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B cell expression of chemokine receptors
B cells that enter GALT follow a chemokine gradient to the FAE where they may
encounter bacteria. These events likely provide the B cells with signals that may lead to
their activation and relocation to other regions of the follicle. To determine whether
bacteria provide such signals, I stimulated stable rabbit B cell lines PBL-1, 55D1 and 79E
for a period of 4 hours through the BCR (goat anti-rabbit IgM) or through TLR2 (TLR
agonist, Pam3Cys4). These three cell lines are at different stages of B cell development:
PBL-1 cells are at a pre-B cell stage (IgMLo B cells); 55D1 are immature B cells (IgMHi B
cells); and 79E are cells that have gone through a germinal center reaction and have
somatically diversified VDJ IgH genes (Sethupathi, et al., 1994). If the stimulation of B
cells through these receptors provides signals that induce their migration, then they
should express specific chemokine receptors on their surface. Since CCR6, CXCR5,
CCR7 and CXCR4 are expressed on B cells as they move throughout the follicle in
GALT (Hanson and Lanning, 2008; Knight Lab working model), I decided to test their
expression on the stimulated B cells.
I found that that the expression of all four chemokine receptors CCR6, CXCR5,
CCR7 and CXCR4, is up-regulated upon TLR2 stimulation (green histogram) in PBL-1
cells compared to unstimulated cells (red histogram). In contrast, the cells that were
stimulated through the BCR (blue histograms) did not express these chemokine receptors
relative to the unstimulated control (Figure 16A-D).
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The detection of chemokine receptor expression on 55D1 cells is shown in Figure
17. I observed that upon TLR2 stimulation (green histogram), 55D1 expressed CCR6
(Fig. 17A), but not CXCR5, CCR7 or CXCR4 (Fig. 17B-D). Interestingly, when the
cells were stimulated though the BCR (blue histogram) some chemokine receptors were
down-regulated: CXCR5, CCR7 and partially CCR6 (fig. 17A-C). CXCR4 was not
affected by stimulation through either receptor (Fig. 17D).
The same process of stimulation applied to PBL-1 and 55D1 B cells was used on
79E cells. I observed a significant up-regulation of CCR6 upon stimulation through
TLR2 compared to the unstained control (Fig. 18A); CCR7 and CXCR4 were slightly upregulated as well (Fig. 18, C&D). Only CCR7 was slightly up-regulated upon
stimulation through BCR (Fig. 18C); the other chemokine receptors were not affected by
stimulation through BCR (Fig. 18A, B&D).
Overall, the results from these experiments suggest that stimulation through TLR2
on stable rabbit B cells provide signals that induce the activation of chemokine receptors.
These data support the idea that bacteria provide B cells with signals that may lead to
their migration to other regions of the GALT follicles.

B cell activation in vitro
B cell activation is initiated following the recognition of antigen through the BCR
and results in B cell proliferation and differentiation. The binding of specific antigen to
the BCR initiates intracellular signaling and results in B cell activation (Harwood and
Batista, 2010). TLR signaling, which occurs by bacterial molecules, is also involved in
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Figure 16: Flow cytometric analysis of chemokine receptor expression on
PBL-1cells. Rabbit B cells PBL-1 were stimulated for 4 hours with goat antirabbit IgM (1:10) (blue), with 10µg/mL TLR2,6 agonist Pam3Cys2 (green), or
left unstimulated (red). The cells were stained with A) PECy5.5-conjugated
RbCCL20-Ig against CCR6, B) APC-conjugated anti-HuCXCR5, C) PEconjugated anti-HuCCR7, and D) PECy7-conjugated anti-HuCXCR4. The
analysis was performed in a CantoII flow cytometer.
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Figure 17: Flow cytometric analysis of chemokine receptor expression on
55D1cells. Rabbit B cells 55D1 were stimulated for 4 hours with goat anti-rabbit
IgM (1:10) (blue), with 10µg/mL TLR2,6 agonist Pam3Cys2 (green), or left
unstimulated (red). The cells were stained with A) PECy5.5-conjugated
RbCCL20-Ig against CCR6, B) APC-conjugated anti-HuCXCR5, C) PEconjugated anti-HuCCR7, and D) PECy7-conjugated anti-HuCXCR4. The
analysis was performed in a CantoII flow cytometer.
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Figure 18: Flow cytometric analysis of chemokine receptor expression on 79E
cells. Rabbit B cells 79E were stimulated for 4 hours with goat anti-rabbit IgM
(1:10) (blue), with 10µg/mL TLR2,6 agonist Pam3Cys2 (green), or left
unstimulated (red). The cells were stained with A) PECy5.5-conjugated
RbCCL20-Ig against CCR6, B) APC-conjugated anti-HuCXCR5, C) PEconjugated anti-HuCCR7, and D) PECy7-conjugated anti-HuCXCR4. The
analysis was performed in a CantoII flow cytometer.
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multiple stages of B cell activation and differentiation (Pasare and Medzhitov, 2005). All
TLR signaling pathways culminate in activation of the transcription factor nuclear factorkappaB (NF-κB), which controls the expression of an array of inflammatory cytokine
genes (Kawai and Akira, 2007). In the following series of experiments, I tested if
bacterial molecules activate B cells by testing for activation of NF-κB, expression of the
activation marker, B7, and for altered expression of chemokine receptors.

NF-κB-Luciferase detection in activated B cells
To determine if bacterial molecules stimulate B cell activation in vitro, I
transfected rabbit B cell lines PBL-1, 55D1 and 79E with an NFκB-Luciferase reporter
vector (5kb). In addition, the cells were co-transfected with pCEP4 (10kb) because the
Luciferase reported construct did not have a selectable marker for mammalian cells.
PCEP4 contains a hygromycin selection gene for mammalian cells, and I used
hygromycin to select stable transfectants. Genomic DNA was isolated from stable
transfectants and PCR was performed to check for the presence of the Luciferase gene.
By PCR analysis, I did not find a band corresponding to the Luciferase (luc) gene
(169bp in size). I repeated these transfections in two additional experiments, and each
time I did not find the luc gene; consequently, I abandoned this approach. A
representative experiment is depicted in Figure 19. The expected size band (169bp)
indicating that the cells contained the Luciferase gene was not observed in neither 79E
cells (Fig. 19A), nor 55D1 cells (Fig 19B).
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It is possible that the assay did not work because instead of using an excess of
NFκB-Luciferase vector over pCEP4 to enhance the chances of obtaining transfectans, I
used equal molar amounts of pCEP4 and NFκB-Luciferase.

Expression of B7 on activated B cells
B7 is normally up-regulated on B cells following activation by cytokines, or
ligation of cell surface molecules (e.g. MHC class II and CD40). In addition, B7 can be
rapidly induced on B cells following activation by cross-linking the BCR
(Jirapongsananuruk, 1999).
As another means of testing if rabbit B cells can be activated by bacterial
molecules, I stimulated B cells and tested for the expression of B7. I stimulated the
stable rabbit B cell line 55D1 in vitro for 4 hours with sonicated B. pumilus, with purified
exopolysaccharide (eps) from Bacillus subtilis (sinRtasA), or with a similar
polysaccharide preparation derived from a B. subtilis mutant (sinRtasAepsH). To assess
for B cell activation I detected the expression of B7, present on activated B cells but not
on resting B cells. Since B7 is the ligand for CTLA-4 (Linsley, 1991), a T cell surface
molecule, I used biotinylated CTLA4-Ig to detect the expression of B7. The stimulated
cells were analyzed by flow cytometry.
My expectation was that if bacterial molecules can activate B cells, then I would
find up-regulation of B7 on the surface of 55D1 cells after exposure to bacterial
molecules. The histograms depicted in Figure 20 are the result of two independent
experiments. The first experiment showed that B7 is up-regulated upon stimulation with
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the eps from B. subtilis (green histogram) but not when stimulated with the
polysaccharide preparation of the mutant (red histogram) (Fig. 20A). I also found that
sonicated B. pumilus induced the up-regulation of B7 (green histogram), compared to the
unstimulated control (red histogram) (Fig. 20B).
In a second experiment, I confirmed that B. subtilis eps stimulated the expression
or up-regulation of B7 (Fig. 20C, green histogram) compared to the unstimulated control
(red histogram). However, I also found that the mutant polysaccharide preparation also
stimulated the expression of B7 (Fig. 20D, green histogram).
The results of this experiment suggested that, exopolysaccharides from B. subtilis
as well as B. pumilus surface molecules can activate 55D1 B cells. I repeated this
experiment twice and found that in addition to the eps, other unidentified B. subtilis
polysaccharide molecule(s), found in the mutant preparation, can also induce the upregulation of B7.

Expression of chemokine receptors on activated B cells
The results obtained above suggest that rabbit B cells can be activated by bacterial
molecules (e.g. eps). In addition, I have demonstrated that stimulation through TRL2
using a TLR agonist induces the expression or up-regulation of chemokine receptors.
These two findings support the idea that in the rabbit GALT, bacteria can provide B cells
with signals that may lead to their activation and relocation to other regions of the
follicle.
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A)

B)

Figure 19: PAGE of PCR-amplified Luciferase gene from transfected rabbit
B cells. A) 79E cells and B) 55D1 cells were transfected with 10µg pNF-κB-Luc
and 4µg pCEP4. Genomic DNA was extracted from each cell type and PCR
amplified using Luciferase internal primers. pNF-κB was the positive control,
and the negative control was without genomic DNA. The expected product size
was 169bp.
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To determine whether bacteria can provide such signals, I stimulated stable rabbit
B cell lines PBL-1and 55D1 for a period of 4 hours with sonicated B. pumilus, B. subtilis
eps, and the mutant strain polysaccharide preparation. These molecules can activate B
cells (Fig. 20). If the activation of B cells is linked to the expression of molecules
involved in migration, then I would expect to detect the up-regulation of chemokine
receptors CCR6, CXCR5, CCR7 and CXCR4 upon B cell activation. These receptors are
expressed on B cells as they move throughout the follicle in GALT.
I observed that PBL-1 cells did not up-regulate CCR6, CXCR5 and CCR7 (Fig.
21A-C, left) upon stimulation with sonicated B. pumilus (green histogram), eps (blue
histogram) or the mutant polysaccharide (brown histogram). However, CXCR4 was
slightly up-regulated upon sonicated B. pumilus stimulation (Fig. 21D, LEFT, green
histogram) compared to unstimulated cells (red histogram). CXCR4 was also upregulated to a lesser extent upon stimulation with eps or the mutant preparation (Fig. 21,
E&F, LEFT, green histograms). Stimulation though BCR (green histogram) and TLR2
(blue histogram) (Fig. 21A-D, RIGHT) confirmed the results shown in Figure 16.
Similar results were obtained with stimulated 55D1 B cells. Once again CCR6,
CXCR5 and CCR7 were not up-regulated upon stimulation with bacterial molecules (Fig.
22A-C) compared to unstimulated control (red histogram). Only CXCR4 appeared to be
slightly up-regulated upon stimulation with sonicated B. pumilus (green histogram), eps
(blue histogram) and the mutant polysaccharide preparation (brown histogram).
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Stimulation through BCR and TLR2 (data not shown) confirmed the results shown in
Figure 16.
The data provided by these experiments do not explain if the activation of B cells
is linked to the expression of molecules involved in migration, such as chemokine
receptors CCR6, CXCR5, CCR7 and CXCR4.
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A)

B)

C)

D)

Figure 20: Flow cytometric analysis of B7 expression on 55D1cells. Rabbit B
cells 55D1 were stimulated for 4 hours with A&C) 2.5µg/mL eps from Bacillus
subtilis, or with D) B. subtilis eps null mutant preparation, or with B) 200µL
sonicated Bacillus pumilus. The cells were stained with biotinylated CTLA4-Ig,
followed by APC-conjugated Streptavidin. The cells were analyzed in the
CantoII cytometer.
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A)

B)

C)
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D)

E)

F)

76
Figure 21: Flow cytometric analysis of chemokine receptor expression on
activated B cells. Rabbit B cells PBL-1 were stimulated for 4 hours with LEFT
SIDE: sonicated B. pumilus (green), 2.5µg/mL eps from Bacillus subtilis (blue),
2.5µg/mL B. subtilis eps null mutant preparation (brown), or left unstimulated
(red); RIGHT SIDE: goat anti-rabbit IgM (1:10) (green), with 10µg/mL TLR2,6
agonist Pam3Cys2 (blue), or left unstimulated (red). The cells were stained with
A) PECy5.5-conjugated RbCCL20-Ig against CCR6, B) APC-conjugated antiHuCXCR5, C) PE-conjugated anti-HuCCR7, and D-F) PECy7-conjugated antiHuCXCR4. The analysis was performed in a CantoII flow cytometer.
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A)

B)

C)

D)

Figure 22: Flow cytometric analysis of chemokine receptor expression on
activated B cells. Rabbit B cells 55D1 were stimulated for 4 hours with sonicated
B. pumilus (green), 2.5µg/mL eps from Bacillus subtilis (blue), 2.5µg/mL B.
subtilis eps null mutant preparation (brown), or left unstimulated (red). The cells
were stained with A) PECy5.5-conjugated RbCCL20-Ig against CCR6, B) APCconjugated anti-HuCXCR5, C) PE-conjugated anti-HuCCR7, and D) PECy7conjugated anti-HuCXCR4. The analysis was performed in a CantoII flow
cytometer.

CHAPTER FOUR
DISCUSSION

The intestinal microbiota has a role in the generation and diversification of B cells
in the GALT of rabbits. The interactions between the host and intestinal microbiota alter
the B cell repertoire in an antigen- and T cell-independent manner. In the process of
elucidating the mechanism by which the above mentioned processes occur, I isolated and
identified bacterial species from the appendix of rabbits that bind to B cell surface Ig.
Using FvIg recombinant molecules I successfully detected a ~20kDa molecule from the
isolated intestinal bacteria. I also showed that molecules from these bacterial species
bind to rabbit serum Ig. My in vitro experiments collected evidence that suggest that
bacterial molecules provide signals through BCR, TLR2 or both, that stimulate the
activation of rabbit B cells. By performing stimulation experiments, I found that
stimulation through TLR2 alters the expression of chemokine receptors on the surface of
B cells; and that their expression varies with the stage of development of the cell.
These findings provide insights into the mechanism by which the microbiota
provide rabbit B cells with signals that may lead to their activation and relocation to other
regions of the follicle in GALT. In the following sections, I will discuss how these
findings contribute to the current model of B cell development and expansion.
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Intestinal bacterial molecules bind Ig
B cell expansion and the somatic diversification of Ig genes in the GALT of
rabbits occur in an antigen- and T cell-independent mechanism (Pospisil and Mage, 1998;
Yeramilli and Knight, 2010). The process of somatic diversification requires interaction
of GALT with intestinal microbiota (Rhee, et al., 2004). At least one study suggests that
B cells can be polyclonally stimulated in vitro by bacteria through the engagement of
IgM by B cell superantigens (Severson, 2010).
The expansion of B cells and somatic diversification of Ig genes is polyclonal and
seems to occur independent of specific antigen. This led us initially to hypothesize that
bacteria express a superantigen-like molecule that binds to the VH and/or VL region of
IgM on the surface of rabbit B cells, independent of their antigen specificity, triggering
the expansion of B cells in GALT. Since in Alicia rabbits the expansion of VHa allotype
over VHn allotype B cells occurs upon contact with microbiota (Rhee, et al., 2004), we
also hypothesized that the putative bacterial superantigen binds to VHa B cells but not
VHn B cells in GALT.
With this idea in mind, I isolated three species of interest, B. pumilus, B.
thuringiensis and P. acnes, from the appendix of rabbit using a+FvIg (VHa) and a-FvIg
(VHn) molecules. I performed a series of experiments to validate the initial hypothesis,
including re-screening experiments by flow cytometry to confirm the results obtained by
FACS sorting; however, the obtained results were very inconsistent.
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I found that the condition of the culture (e.g. liquid culture versus agar plate
culture), as well as the maturity of the culture influenced whether the isolates bound to
VHa or VHn allotypes (FvIg). It is possible that the inconsistent binding to FvIg was due
to transient expression of the bacterial molecule(s) from the isolated species. Perhaps
such molecule(s) is only expressed at specific stages during bacterial growth. This can be
assessed by obtaining time-point samples of a growing culture, staining them with FvIg
and performing flow cytometry experiments to determine if there is a difference in
binding activity to FvIg. It is also possible that the nutrients present in the growth media
influence the metabolism of the specie, altering the expression of the putative bacterial
molecule(s). A logical approach to solve this enigma is to expose the isolates to different
culture conditions and perform binding experiments to determine the optimal condition
where bacteria express such molecule(s).
During these experiments, I successfully identified a ~20kDa bacterial molecule
from the surface of B. pumilus, B. thuringiensis and P. acnes, that immunoprecipitated
with both a+FvIg and a-FvIg. These data indicated that bacterial molecules can bind Ig,
and supported the idea that in the FAE, bacteria provide B cells with signals that may
lead to their activation. On the other hand, these results also led us to speculate that the
inconsistent binding to FvIg observed by flow cytometry experiments were due to
transient expression of this ~20kDa molecule. This question can be answered by growing
the isolates under different conditions and performing immunoprecipitation experiments
in each case using FvIg molecules. This will allow determining if the ~20kDa molecule
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is transiently expressed on these species, and if it can be responsible for the inconsistent
results observed by the flow cytometric experiments.
I also found that B. pumilus molecules, other than the ~20kDa molecule
immunoprecipitated by FvIg, bound directly to different regions of serum IgG from
rabbit, human or goat species. In addition, I observed that the same bacterial molecules
did not bind to the same sites on the IgG from these three animals. These observations
not only confirm that Ig molecules from different species are unique to that species, but
also suggest that the same bacteria can bind to different regions of IgG, depending on the
species. These results provide further evidence that bacterial molecules can bind Ig. This
finding is consistent with the hypothesis that in the FAE, bacterial molecules may bind to
B cells through surface Ig, providing signals that may stimulate B cell activation.
Newborn Alicia rabbits possess a predominant VHn B cell population, but as these
rabbits age, the number of VHa B cells increases, becoming the predominant allotype
(Pospisil and Mage, 1998; Zhu, 1999). Their VHa B cell population lacks the IgH VH
gene segment, VH1. Instead, the majority of the VDJ rearrangements in these rabbits
utilize the functional VH4 gene (Zhu, 1999). Because the expansion of VHa B cells occurs
with age and upon contact with bacteria (Rhee, et al., 2004), it is apparent that the ali/ali
rabbits offer a unique opportunity to understand the selective forces brought to the
immune system by the intestinal microbiota.
One of my goals during this study was to test if bacteria from the intestine of
Alicia rabbits interact with the Ig of VHa but not VHn B cells, thereby inducing the
expansion of VHa B cells. My strategy was to substitute the VH1 gene present in the FvIg
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constructs (Severson, 2010) by the VH4 gene which is used in many B cells of ali/ali
rabbits. During my cloning experiments I successfully obtained the correct sequence of a
complete FvIg molecule containing the VH4 gene. However, after further testing I found
that the FvIg protein was not expressed by the transfected mammalian CHO cells (see
Chapter 2, Materials and Methods). Although I revised and adjusted my cloning strategy
several times, I was unable to achieve complete expression of the FvIg molecules, and I
abandoned this plan.
Previously, I successfully demonstrated that bacterial molecules can bind Ig,
supporting the idea that in the FAE, bacteria provide B cells with signals that may lead to
their activation. As a consequence, I became interested in investigating the mechanism
by which commensals drive GALT reactions, particularly the processes that lead to the
activation and migration of B cells in GALT.

B cell activation and expression of B7
The activation of B cells can occur by BCR crosslinking (Harwood and Batista,
2010); through TLR stimulation (Pasare and Medzhitov, 2005); or by the combination of
stimuli though more than one surface receptor, including CD40. Previous studies in the
Knight Lab tested B cell activation in rabbit by various methods, including Calcium flux.
The alteration in intracellular calcium ions (Ca2+) is one of the most rapid cellular
responses to a variety of stimuli, and suggests cell activation. However, these
experiments provided inconclusive data.
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One of the most distinctive phenotypes of activated B cells is the surface
expression of B7 (Jirapongsananuruk and Leung, 1999). I reasoned that the detection of
B7 would be a direct and effective method for the recognition of activated B cells. The
first problem I encountered while carrying out these experiments was the unavailability
of antibodies against rabbit B7. I solved this problem by using soluble receptor,
biotinylated rabbit CTLA4-Ig to detect the expression of B7. The T cell surface molecule
CTLA4 is a receptor for B7 (Linsley, 1991).
I chose to use the stable rabbit cell line 55D1 to determine if bacterial molecules
provide signals that may induce the activation of B cells. Other stable cell lines, such as
PBL-1 and 79E, were less favored choices since they are at an early stage of development
(PBL-1) and at a later one (79E) (Sethupathi, et al., 1994).
I found that exopolysaccharide from B. subtilis, as well as B. pumilus surface
molecules can activate 55D1 rabbit B cells. These findings support the idea that B cells
can interact with specific bacterial molecules in the FAE of the follicle; and that this
interaction may provide signals that induce the activation of B cells.
One of the caveats of stimulating cells with sonicated bacteria (B. pumilus) was
that I had no means to determine the identity of the molecule(s) inducing the activation of
55D1 cells. In addition, I could not estimate the concentration of the molecule(s)
involved in the stimulation of the cells. One way to solve this problem is to identify by
mass spectrometry the ~20kDa detected by FvIg molecules. Once identified, the protein
could be purified and used for stimulation experiments. Although I demonstrated that
this molecule binds to Ig molecules, it is possible that it can also bind to other receptors
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on the surface of B cells, such as TLRs. These questions remain to be answered by future
studies.
The fact that at least one stimulus (B. subtilis eps) is a known purified molecule,
was quite exciting because it provided the opportunity to ask a new set of questions.
However, I found later that B. subtilis polysaccharide(s), the negative control, was also
able to stimulate the activation of B cells. One possibility is that eps and polysaccharide
molecule(s) stimulate B cells through distinct receptors, and that the end result for both
stimuli is the same, the activation of B cells. Other studies in the Knight Lab are
currently trying to determine the specific receptor for B. subtilis eps. Some clues indicate
that such receptor may be TLR2, at least in mice; however, all results are inconclusive
thus far. Finding the receptor for eps would allow for a more extensive understanding of
the mechanism by which bacterial molecules influence B cell expansion. Future
experiments could involve knockout rabbits lacking the putative receptor. This would
provide a tool to ask how this condition can affect B cell expansion and diversification in
rabbits.
During these studies, I also found that 55D1cells were activated when stimulated
with goat anti-rabbit IgM, but only in the absence of CD40L. This is not a surprising
result in view of the fact that activation of B cells can occur by BCR crosslinking
(Harwood and Batista, 2010). Additionally I found that soluble CD40L down-regulates
the expression of B7. It is possible that soluble CD40L was endocytosed by 55D1,
triggering some internal signaling that inhibited activation of B cells and by association,
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the expression of surface B7. It is also possible that the activation of the cells was not
affected, but for some unexplainable reason, the expression of B7 was inhibited.

B cell expression of chemokine receptors
The Knight Lab has gathered evidence over the past decades to support the idea
that bacteria from the intestines of rabbits are required for the expansion and migration of
B cells in GALT. A portion of this compilation of evidence has been converted into a
simplified working model (Fig. 23) that proposes the mechanism by which B cells
migrate throughout the follicle. This model suggests that B cells that enter the follicle
follow a chemokine gradient that starts at the FAE, and concludes at the basolateral end
of the follicle, where cell proliferation and Ig diversification occur.
Most of the results contributing to this model were obtained by in situ
hybridization studies (Hanson and Lanning, 2008), which provide the exact location of
chemokine expression in the follicle. These chemoattractants are CCL20, CXCL13,
CCL21 and CXCL12. Flow cytometric experiments in which primary B cells from the
appendix of rabbits are stained with antibodies against chemokine receptors demonstrate
that these cells express CCR6, CXCR5, CCR7 and CXCR4 receptors (unpublished
results). These are the receptors for the ligands detected by in situ hybridization
experiments, respectively.
One of the obstacles encountered when working with primary cells from the
appendix of young rabbits is that the isolated B cells die at a fast rate. In addition to this,
it is difficult to obtain a homogeneous B cell population from a tissue so rich in other cell
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types (e.g. epithelial cells and stromal cells). To overcome this obstacle, I tested stable
rabbit B cell lines with the idea of generating an in vitro system that would facilitate
asking questions about B cell migration in GALT.
Since our model suggests that B cells leave the BM marrow and migrate to
GALT, I reasoned that PBL-1, an early stage B cell, would successfully mimic these
resting B cells from the BM. In our model, naïve B cells migrate to the FAE and become
activated by bacterial molecules. To better study the fate of these activated B cells in the
follicle, I decided to test 55D1 cells, a more mature cell line. Finally, I needed a cell line
that had already gone through the diversification of V(D)J genes. This cell line (79E)
would be used to study the cells found in the basolateral end of the follicle.
One of the major difficulties encountered when working with rabbits is the lack of
antibody reagents against molecules of this species. I was able to circumvent this issue
by using human antibodies that react against rabbit protein, generously provided by Dr.
Dennis Lanning.
I found that that the expression of all four chemokine receptors CCR6, CXCR5,
CCR7 and CXCR4, is up-regulated upon TLR2 stimulation in PBL-1 cells. TLR2
recognizes bacterial lipoproteins and peptidoglycans (Forchielli, 2005). One of the major
caveats to this experiment, and to other experiments with 55D1 and 79E cells, is that
instead of using bacterial molecules to stimulate the cells, I used the TLR2,6 agonist,
Pam3CSK4. Nevertheless, I demonstrated that early stage PBL-1 cells can express all
four chemokine receptors detected in primary cells from the appendix (Hanson and
Lanning, 2008; Knight Lab working model). I also stimulated PBL-1 for 24 hours with
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the same reagents, but the results were comparable to the results I obtained by stimulating
the cells for 4 hours. This suggests that the expression of chemokine receptors in
stimulated cells is a stable rather than a transient event. The cells were also stimulated in
the presence of CD40L, since CD40 is essential in B cell activation (Pasare and
Medzhitov, 2005). However, whether CD40 was present or absent, the results were the
same (data not shown). PBL-1 cells were also stimulated with LPS (against TLR4) and
the TLR1,2 agonist Pam2CSK4, but the results did not differ from the unstimulated
control (data not shown).
The stimulation of 55D1 and 79E cells through TLR2 resulted in the upregulation of CCR6 but not CXCR5, CCR7 and CXCR4. This was more apparent in 79E
cells. Once again, these cells were stimulated in the presence of CD40L, but this factor
did not make a difference in the expression of chemokine receptor in these cells.
Stimulation with LPS and Pam2CSK4 was comparable to the unstimulated control.
In summary, these data suggested that TLR2 stimulation alter the chemokine
expression of B cells, and may be important in the migration of B cells in GALT. It is
not surprising that LPS did not stimulate PBL-1, 55D1 or 79E cells, since it has been
known for many years that rabbit B cells do not react to this bacterial molecule. The
finding that Pam2CSK did not stimulate the expression of any of the four chemokine
receptors suggests that TLR1 may not contribute to the migration of B cells in GALT.
Stimulation through BCR appears to play a lesser role than TLR2 in this process,
as evidenced by the downregulation of CXCR5, CCR6 and CCR7 in 55D1cells but not in
PBL-1 and 79E cells. It was not completely surprising that PBL-1 cells did not express
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any of the chemokine receptors upon BCR stimulation, given that these cells are IgMLo B
cells (Sethupathi, et al., 1994).
The different levels of expression of chemokine receptors in the three B cell lines
might be due to their stage of development, and not completely on the nature of the
stimuli. Another possibility is that B cells leaving the BM may initially have the capacity
to upregulate all four chemokine receptors upon stimuli, but the expression of selected
receptors is lost after receiving a variety of peripheral signals.
The data collected by these in vitro studies (Table 3) suggest that stimulation
through TLR2 on rabbit B cells provide signals that induce the activation of some
chemokine receptors. These findings further support the idea that bacteria provide B
cells with signals that may lead to their activation and movement to other regions of the
GALT follicles.
B cells leave the BM and enter GALT two days after birth. Previous studies in
the Knight Lab have demonstrated that a+FvIg but not a-FvIg binds M cells in the FAE,
suggesting that early in development, the expansion of VHa B cells but not VHn B cells
occurs by events taking place in the FAE. However, in later experiments, proliferating
VHn B cells were detected in the basolateral end of the follicle, contradicting their initial
observation. These findings suggested that the initial activation of B cells in the early
stages of the GALT response do not require migration to the FAE; and that the selective
expansion of B cells can occur after B cell proliferation and somatic diversification of Ig
genes. According to these findings, it is possible that somatically diversified B cells
traffic back to the FAE where bacterial molecules provide B cells with signals that lead to
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Figure 23: Knight Lab model of B cell migration in GALT. Resting B cells
leave the BM approximately 2 days after birth and enter GALT. Once in GALT,
B cells expressing CCR6 follow a chemokine gradient to the FAE (dome), where
CCL20 is produced by epithelial cells. In this region, B cells may encounter
bacterial molecules which provide B cells with signals for migration. The cells
express CXCR5 and migrate next to the FDC zone, where CXCL13 is produced.
B cells receive extra stimulatory signals from FDC, upregulate CCR7, and
migrate to the T cell areas, attracted to CCL21. Finally, B cells expressing
CXCR4 migrate to the basolateral end of the follicular area, where CXCL12 is
expressed. In this area, the cells proliferate and the Ig genes undergo somatic
diversification.
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Table 3: Summary of chemokine receptor expression on rabbit B cell lines

Stimuli

PBL-1

55D1

79E

BCR

NC*

-

NC

TLR2

+++

+

+++

BCR

NC

---

NC

TLR2

++

NC

NC

BCR

NC

---

-

TLR2

++

NC

NC

BCR

NC

NC

NC

TLR2

++

NC

NC

CCR6

CXCR5

CCR7

CXCR4

+ low expression
++ medium expression
+++ high expression
- slight downregulation
--- high downregulation
* NC = no change
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their migration in GALT. The observation that PBL-1, 55D1 and 79E B cells all express
CCR6 upon stimulation through TLR2 supports this idea.
It is possible that a group of early stage B cells expressing CCR6, like PBL-1
cells, enter GALT and follow the chemokine gradient to the FAE, where they are exposed
to certain environmental and survival signals that lead them to migrate to the basolateral
end of the follicle. In the basolateral end of the follicle, the cells undergo somatic
hypermutation and Ig diversification (like 79E cells). Following a chemokine gradient
and other environmental signals, the somatically diversified cells traffic back to the FAE
and encounter bacterial molecules from the expanding population of commensals. These
events may trigger signals that induce the expansion of B cells in GALT and the
migration to the periphery.

Bacterial molecules and B cell migration

As discussed above, I successfully demonstrated in vitro that bacterial molecules
can induce the activation of rabbit B cells. In addition to this, I demonstrated that
stimulation through the pattern recognition receptor (PRR) TLR2 can induce the
expression of certain chemokine receptors on the surface of B cells. However, these
findings do not demonstrate that bacteria provide signals for B cell migration.
B. subtilis eps and B. pumilus molecules can stimulate the activation of B cells as
evidenced by the expression of B7. On the other hand, PPRs like TLRs can recognize
bacterial patterns. S. Jain (2013) demonstrated that the simultaneous signaling through
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TLR2 and B7 results in the activation of resting B cells. Therefore, it was possible that
eps and B. pumilus molecules could also stimulate the expression of chemokine receptors
on activated B cells. To test this idea, I selected PBL-1 and 55D1 B cells. I reasoned that
the majority of chemokine receptor expression or downregulation upon stimulation
occurred in these two cell lines (Table 3), and not so much in 79E cell.
I observed that neither PBL-1, nor 55D1 B cells upregulated CCR6, CXCR5 and
CCR7 when stimulated with bacterial molecules; and only CXCR4 was slightly upregulated upon stimulation with B. pumilus molecules. It is possible that eps and/or B.
pumilus molecules stimulate rabbit B cells through BCR only, or through other
unidentified receptor(s) not involved in B cell migration. Although it was mentioned
before that TLR2 could be the receptor for eps, this is not yet confirmed.
These experiments were performed once and their results are not sufficient to
formulate a strong conclusion. The data provided by these experiments do not explain if
the activation of B cells is linked to the expression of molecules involved in migration,
such as chemokine receptors CCR6, CXCR5, CCR7 and CXCR4.

CONCLUSION
For many years the Knight Lab has been focusing on experiments designed to
identify the bacterial molecule(s) that drives the activation and migration of B cells in the
GALT of rabbits. In addition, our Lab has been trying to determine the role of intestinal
bacteria in the mechanism of selection of VHa B cells in rabbits.
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The initial goal of this research was to determine the mechanism of selection of
VHa B cells in rabbits. To test this idea, I isolated three species of interest, B. pumilus, B.
thuringiensis and P. acnes, which were identified by ribosomal 16sRNA sequencing.
During these experiments, I successfully identified a ~20kDa bacterial molecule from the
isolated intestinal bacteria that immunoprecipitated with FvIg molecules. These data
indicated that bacterial molecules can bind Ig, and supported the idea that in the FAE,
bacteria provide B cells with signals that may lead to their activation.
However, over the course of my study I became interested in the mechanism by
which bacterial molecules drive the activation and migration of B cells in the GALT of
rabbits. While testing this question, I showed that bacterial molecules provide signals,
through surface receptors (BCR and/or TLR2), that stimulate the activation of rabbit B
cells. I also demonstrated that stimulation through TLR2 alters the expression of
chemokine receptors on the surface of B cells.
These studies provide additional evidence in the quest to elucidate the mechanism
by which interactions between the host and intestinal microbiota alter the B cell
repertoire in an antigen independent manner.
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